Form 10-Q
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
x |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the quarterly period ended March 31, 2016
or
¨ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
For the transition period
from
to |
|
|
Commission File Number: 001-14965
The Goldman Sachs Group, Inc.
(Exact name of registrant as specified in its charter)
|
|
|
Delaware |
|
13-4019460 |
(State or other jurisdiction of
incorporation or organization) |
|
(I.R.S. Employer
Identification No.) |
|
|
200 West Street, New York, N.Y. |
|
10282 |
(Address of principal executive offices) |
|
(Zip Code) |
(212) 902-1000
(Registrants telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d)
of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. x Yes ¨ No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every
Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post
such files). x Yes ¨ No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or
a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.
|
|
|
Large accelerated filer x
Accelerated filer ¨ |
|
Non-accelerated filer ¨ (Do not check if a smaller reporting
company) Smaller reporting company ¨ |
Indicate by check mark whether the registrant is a shell company (as defined in
Rule 12b-2 of the Exchange Act). ¨ Yes x No
APPLICABLE ONLY TO CORPORATE ISSUERS
As of April 22, 2016, there were 415,394,033 shares of the registrants common stock outstanding.
THE GOLDMAN SACHS GROUP, INC.
QUARTERLY
REPORT ON FORM 10-Q FOR THE QUARTER ENDED MARCH 31, 2016
INDEX
|
|
|
|
|
Form 10-Q Item Number |
|
Page No. |
|
PART I |
|
FINANCIAL INFORMATION |
|
2 |
|
Item 1 |
|
Financial Statements (Unaudited) |
|
2 |
|
|
|
Condensed Consolidated Statements of Earnings for the three months ended March 31, 2016
and March 31, 2015 |
|
2 |
|
|
|
Condensed Consolidated Statements of Comprehensive Income for the three months
ended March 31, 2016 and March 31, 2015 |
|
3 |
|
|
|
Condensed Consolidated Statements of Financial Condition as of March 31, 2016
and December 31, 2015 |
|
4 |
|
|
|
Condensed Consolidated Statements of Changes in Shareholders Equity for
the three months ended March 31, 2016 and year ended December 31, 2015 |
|
5 |
|
|
|
Condensed Consolidated Statements of Cash Flows for the three months ended
March 31, 2016 and March 31, 2015 |
|
6 |
|
|
|
Notes to Condensed Consolidated Financial Statements |
|
7 |
|
|
|
Note 1.
Description of Business |
|
7 |
|
|
|
Note 2.
Basis of Presentation |
|
7 |
|
|
|
Note 3.
Significant Accounting Policies |
|
8 |
|
|
|
Note 4.
Financial Instruments Owned, at Fair Value and Financial Instruments Sold, |
|
|
|
|
But Not Yet Purchased, at Fair Value |
|
14 |
|
|
|
Note 5.
Fair Value Measurements |
|
15 |
|
|
|
Note 6.
Cash Instruments |
|
16 |
|
|
|
Note 7.
Derivatives and Hedging Activities |
|
22 |
|
|
|
Note 8.
Fair Value Option |
|
34 |
|
|
|
Note 9.
Loans Receivable |
|
40 |
|
|
|
Note 10.
Collateralized Agreements and Financings |
|
44 |
|
|
|
Note 11.
Securitization Activities |
|
48 |
|
|
|
Note 12.
Variable Interest Entities |
|
50 |
|
|
|
Note 13. Other
Assets |
|
53 |
|
|
|
Note 14. Deposits |
|
56 |
|
|
|
Note 15. Short-Term
Borrowings |
|
56 |
|
|
|
Note 16. Long-Term
Borrowings |
|
57 |
|
|
|
Note 17.
Other Liabilities and Accrued Expenses |
|
59 |
|
|
|
Note 18.
Commitments, Contingencies and Guarantees |
|
60 |
|
|
|
Note 19.
Shareholders Equity |
|
65 |
|
|
|
Note 20.
Regulation and Capital Adequacy |
|
67 |
|
|
|
Note 21.
Earnings Per Common Share |
|
76 |
|
|
|
Note 22.
Transactions with Affiliated Funds |
|
76 |
|
|
|
Note 23.
Interest Income and Interest Expense |
|
77 |
|
|
|
Note 24. Income
Taxes |
|
78 |
|
|
|
Note 25. Business
Segments |
|
79 |
|
|
|
Note 26. Credit
Concentrations |
|
81 |
|
|
|
Note 27. Legal
Proceedings |
|
82 |
|
|
|
Report of Independent Registered Public Accounting
Firm |
|
90 |
|
|
|
Statistical Disclosures |
|
91 |
|
Item 2 |
|
Managements Discussion and Analysis of Financial Condition and Results
of Operations |
|
92 |
|
Item 3 |
|
Quantitative and Qualitative Disclosures About Market
Risk |
|
154 |
|
Item 4 |
|
Controls and Procedures |
|
154 |
|
PART II |
|
OTHER INFORMATION |
|
154 |
|
Item 1 |
|
Legal Proceedings |
|
154 |
|
Item 2 |
|
Unregistered Sales of Equity Securities and Use of
Proceeds |
|
155 |
|
Item 6 |
|
Exhibits |
|
155 |
|
SIGNATURES
|
|
156 |
|
|
|
|
|
|
|
Goldman Sachs March 2016 Form 10-Q |
|
1 |
PART I. FINANCIAL INFORMATION
ITEM 1. Financial Statements (Unaudited)
THE
GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Earnings
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
Three Months
Ended March |
|
in millions, except per share amounts |
|
|
2016 |
|
|
|
2015 |
|
Revenues |
|
|
|
|
|
|
|
|
Investment banking |
|
|
$1,463 |
|
|
|
$ 1,905 |
|
|
|
Investment management |
|
|
1,262 |
|
|
|
1,503 |
|
|
|
Commissions and fees |
|
|
917 |
|
|
|
853 |
|
|
|
Market making |
|
|
1,862 |
|
|
|
3,925 |
|
|
|
Other principal transactions |
|
|
(49 |
) |
|
|
1,572 |
|
Total non-interest revenues |
|
|
5,455 |
|
|
|
9,758 |
|
|
|
Interest income |
|
|
2,348 |
|
|
|
2,035 |
|
|
|
Interest expense |
|
|
1,465 |
|
|
|
1,176 |
|
Net interest income |
|
|
883 |
|
|
|
859 |
|
Net revenues, including net interest income |
|
|
6,338 |
|
|
|
10,617 |
|
Operating expenses |
|
|
|
|
|
|
|
|
Compensation and benefits |
|
|
2,662 |
|
|
|
4,459 |
|
|
|
Brokerage, clearing, exchange and
distribution fees |
|
|
691 |
|
|
|
638 |
|
|
|
Market development |
|
|
122 |
|
|
|
139 |
|
|
|
Communications and technology |
|
|
197 |
|
|
|
198 |
|
|
|
Depreciation and amortization |
|
|
239 |
|
|
|
219 |
|
|
|
Occupancy |
|
|
183 |
|
|
|
204 |
|
|
|
Professional fees |
|
|
220 |
|
|
|
211 |
|
|
|
Other expenses |
|
|
448 |
|
|
|
615 |
|
Total non-compensation expenses |
|
|
2,100 |
|
|
|
2,224 |
|
Total operating expenses |
|
|
4,762 |
|
|
|
6,683 |
|
Pre-tax earnings |
|
|
1,576 |
|
|
|
3,934 |
|
|
|
Provision for taxes |
|
|
441 |
|
|
|
1,090 |
|
Net earnings |
|
|
1,135 |
|
|
|
2,844 |
|
|
|
Preferred stock dividends |
|
|
(65 |
) |
|
|
96 |
|
Net earnings applicable to common shareholders |
|
|
$1,200 |
|
|
|
$ 2,748 |
|
Earnings per common share |
|
|
|
|
|
|
|
|
Basic |
|
|
$ 2.71 |
|
|
|
$ 6.05 |
|
|
|
Diluted |
|
|
2.68 |
|
|
|
5.94 |
|
|
|
Dividends declared per common
share |
|
|
$ 0.65 |
|
|
|
$ 0.60 |
|
|
|
Average common shares
outstanding |
|
Basic |
|
|
440.8 |
|
|
|
453.3 |
|
|
|
Diluted |
|
|
447.4 |
|
|
|
462.9 |
|
The accompanying notes are an integral part of these condensed consolidated financial statements.
|
|
|
|
|
2 |
|
Goldman Sachs March 2016 Form 10-Q |
|
|
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Comprehensive Income
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
Three Months
Ended March |
|
$ in millions |
|
|
2016 |
|
|
|
2015 |
|
Net earnings |
|
|
$1,135 |
|
|
|
$2,844 |
|
|
|
Other comprehensive loss adjustments, net of tax: |
|
|
|
|
|
|
|
|
Currency translation |
|
|
(17 |
) |
|
|
(25 |
) |
|
|
Debt valuation adjustment |
|
|
(12 |
) |
|
|
|
|
|
|
Pension and postretirement liabilities |
|
|
(36 |
) |
|
|
(3 |
) |
|
|
Other comprehensive loss |
|
|
(65 |
) |
|
|
(28 |
) |
Comprehensive income |
|
|
$1,070 |
|
|
|
$2,816 |
|
The accompanying notes are an integral part of these condensed consolidated financial statements.
|
|
|
|
|
|
|
Goldman Sachs March 2016 Form 10-Q |
|
3 |
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Financial Condition
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
As of |
|
$ in millions, except per share amounts |
|
|
March 2016 |
|
|
|
December 2015 |
|
Assets |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
|
$ 79,169 |
|
|
|
$ 75,105 |
|
|
|
Cash and securities segregated for regulatory and other purposes (includes $39,505 and $38,504 at fair value
as of March 2016 and December 2015, respectively) |
|
|
58,287 |
|
|
|
56,838 |
|
|
|
Collateralized agreements: |
|
|
|
|
|
|
|
|
Securities purchased under agreements to resell and federal funds sold (includes $127,189 and $119,450 at
fair value as of March 2016 and December 2015, respectively) |
|
|
128,513 |
|
|
|
120,905 |
|
|
|
Securities borrowed (includes $66,212 and $69,801 at fair value as of March 2016 and December 2015,
respectively) |
|
|
180,603 |
|
|
|
172,099 |
|
|
|
Receivables: |
|
|
|
|
|
|
|
|
Brokers, dealers and clearing organizations |
|
|
22,971 |
|
|
|
25,453 |
|
|
|
Customers and counterparties (includes $3,893 and $4,992 at fair value as of March 2016 and
December 2015, respectively) |
|
|
49,399 |
|
|
|
46,430 |
|
|
|
Loans receivable |
|
|
47,924 |
|
|
|
45,407 |
|
|
|
Financial instruments owned, at fair value (includes $53,548 and $54,426 pledged as collateral as of
March 2016 and December 2015, respectively) |
|
|
286,902 |
|
|
|
293,940 |
|
|
|
Other assets |
|
|
24,268 |
|
|
|
25,218 |
|
Total assets |
|
|
$878,036 |
|
|
|
$861,395 |
|
Liabilities and shareholders
equity |
|
|
|
|
|
|
|
|
Deposits (includes $15,034 and $14,680 at fair value as of March 2016 and December 2015,
respectively) |
|
|
$104,866 |
|
|
|
$ 97,519 |
|
|
|
Collateralized financings: |
|
|
|
|
|
|
|
|
Securities sold under agreements to repurchase, at fair value |
|
|
77,617 |
|
|
|
86,069 |
|
|
|
Securities loaned (includes $972 and $466 at fair value as of March 2016 and December 2015,
respectively) |
|
|
4,427 |
|
|
|
3,614 |
|
|
|
Other secured financings (includes $24,394 and $23,207 at fair value as of March 2016 and
December 2015, respectively) |
|
|
26,175 |
|
|
|
24,753 |
|
|
|
Payables: |
|
|
|
|
|
|
|
|
Brokers, dealers and clearing organizations |
|
|
6,027 |
|
|
|
5,406 |
|
|
|
Customers and counterparties |
|
|
204,911 |
|
|
|
204,956 |
|
|
|
Financial instruments sold, but not yet purchased, at fair value |
|
|
127,013 |
|
|
|
115,248 |
|
|
|
Unsecured short-term borrowings, including the current portion of unsecured long-term borrowings (includes
$19,246 and $17,743 at fair value as of March 2016 and December 2015, respectively) |
|
|
46,691 |
|
|
|
42,787 |
|
|
|
Unsecured long-term borrowings (includes $25,671 and $22,273 at fair value as of March 2016 and
December 2015, respectively) |
|
|
180,159 |
|
|
|
175,422 |
|
|
|
Other liabilities and accrued expenses (includes $576 and $1,253 at
fair value as of March 2016 and December 2015, respectively) |
|
|
13,313 |
|
|
|
18,893 |
|
Total liabilities |
|
|
791,199 |
|
|
|
774,667 |
|
|
|
Commitments, contingencies and
guarantees |
|
|
|
|
|
|
|
|
Shareholders equity |
|
|
|
|
|
|
|
|
Preferred stock, par value $0.01 per share; aggregate liquidation preference of $11,203 and $11,200 as of
March 2016 and December 2015, respectively |
|
|
11,203 |
|
|
|
11,200 |
|
|
|
Common stock, par value $0.01 per share; 4,000,000,000 shares authorized, 872,016,591 and 863,976,731 shares
issued as of March 2016 and December 2015, respectively, and 417,572,204 and 419,480,736 shares outstanding as of March 2016 and December 2015, respectively |
|
|
9 |
|
|
|
9 |
|
|
|
Share-based awards |
|
|
3,820 |
|
|
|
4,151 |
|
|
|
Nonvoting common stock, par value $0.01 per share; 200,000,000 shares authorized, no shares issued and
outstanding |
|
|
|
|
|
|
|
|
|
|
Additional paid-in capital |
|
|
52,471 |
|
|
|
51,340 |
|
|
|
Retained earnings |
|
|
83,990 |
|
|
|
83,386 |
|
|
|
Accumulated other comprehensive loss |
|
|
(478 |
) |
|
|
(718 |
) |
|
|
Stock held in treasury, at cost, par value $0.01 per share;
454,444,389 and 444,495,997 shares as of March 2016 and December 2015, respectively |
|
|
(64,178 |
) |
|
|
(62,640 |
) |
Total shareholders equity |
|
|
86,837 |
|
|
|
86,728 |
|
Total liabilities and shareholders equity |
|
|
$878,036 |
|
|
|
$861,395 |
|
The accompanying notes are an integral part of these condensed consolidated financial statements.
|
|
|
|
|
4 |
|
Goldman Sachs March 2016 Form 10-Q |
|
|
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Changes in Shareholders Equity
(Unaudited)
|
|
|
|
|
|
|
|
|
$ in millions |
|
|
Three Months Ended March 2016 |
|
|
|
Year Ended December 2015 |
|
Preferred stock |
|
|
|
|
|
|
|
|
Balance, beginning of year |
|
|
$ 11,200 |
|
|
|
$ 9,200 |
|
|
|
Issued |
|
|
675 |
|
|
|
2,000 |
|
|
|
Redeemed |
|
|
(672 |
) |
|
|
|
|
Balance, end of period |
|
|
11,203 |
|
|
|
11,200 |
|
|
|
Common stock |
|
|
|
|
|
|
|
|
Balance, beginning of year |
|
|
9 |
|
|
|
9 |
|
|
|
Issued |
|
|
|
|
|
|
|
|
Balance, end of period |
|
|
9 |
|
|
|
9 |
|
|
|
Share-based awards |
|
|
|
|
|
|
|
|
Balance, beginning of year |
|
|
4,151 |
|
|
|
3,766 |
|
|
|
Issuance and amortization of share-based awards |
|
|
1,672 |
|
|
|
2,308 |
|
|
|
Delivery of common stock underlying share-based awards |
|
|
(1,971 |
) |
|
|
(1,742 |
) |
|
|
Forfeiture of share-based awards |
|
|
(30 |
) |
|
|
(72 |
) |
|
|
Exercise of share-based awards |
|
|
(2 |
) |
|
|
(109 |
) |
Balance, end of period |
|
|
3,820 |
|
|
|
4,151 |
|
|
|
Additional paid-in capital |
|
|
|
|
|
|
|
|
Balance, beginning of year |
|
|
51,340 |
|
|
|
50,049 |
|
|
|
Delivery of common stock underlying share-based awards |
|
|
1,972 |
|
|
|
2,092 |
|
|
|
Cancellation of share-based awards in satisfaction of withholding tax requirements |
|
|
(881 |
) |
|
|
(1,198 |
) |
|
|
Preferred stock issuance costs, net |
|
|
(14 |
) |
|
|
(7 |
) |
|
|
Excess net tax benefit related to share-based awards |
|
|
54 |
|
|
|
406 |
|
|
|
Cash settlement of share-based awards |
|
|
|
|
|
|
(2 |
) |
Balance, end of period |
|
|
52,471 |
|
|
|
51,340 |
|
|
|
Retained earnings |
|
|
|
|
|
|
|
|
Balance, beginning of year, as previously reported |
|
|
83,386 |
|
|
|
78,984 |
|
|
|
Reclassification of cumulative debt valuation adjustment, net of tax,
to accumulated other comprehensive loss |
|
|
(305 |
) |
|
|
|
|
Balance, beginning of year, adjusted |
|
|
83,081 |
|
|
|
78,984 |
|
|
|
Net earnings |
|
|
1,135 |
|
|
|
6,083 |
|
|
|
Dividends and dividend equivalents declared on common stock and share-based awards |
|
|
(291 |
) |
|
|
(1,166 |
) |
|
|
Dividends declared on preferred stock |
|
|
(96 |
) |
|
|
(515 |
) |
|
|
Preferred stock redemption discount |
|
|
161 |
|
|
|
|
|
Balance, end of period |
|
|
83,990 |
|
|
|
83,386 |
|
|
|
Accumulated other comprehensive loss |
|
|
|
|
|
|
|
|
Balance, beginning of year, as previously reported |
|
|
(718 |
) |
|
|
(743 |
) |
|
|
Reclassification of cumulative debt valuation adjustment, net of tax,
from retained earnings |
|
|
305 |
|
|
|
|
|
Balance, beginning of year, adjusted |
|
|
(413 |
) |
|
|
(743 |
) |
|
|
Other comprehensive income/(loss) |
|
|
(65 |
) |
|
|
25 |
|
Balance, end of period |
|
|
(478 |
) |
|
|
(718 |
) |
|
|
Stock held in treasury, at cost |
|
|
|
|
|
|
|
|
Balance, beginning of year |
|
|
(62,640 |
) |
|
|
(58,468 |
) |
|
|
Repurchased |
|
|
(1,550 |
) |
|
|
(4,195 |
) |
|
|
Reissued |
|
|
19 |
|
|
|
32 |
|
|
|
Other |
|
|
(7 |
) |
|
|
(9 |
) |
Balance, end of period |
|
|
(64,178 |
) |
|
|
(62,640 |
) |
Total shareholders equity |
|
|
$ 86,837 |
|
|
|
$ 86,728 |
|
The accompanying notes are an integral part of these condensed consolidated financial statements.
|
|
|
|
|
|
|
Goldman Sachs March 2016 Form 10-Q |
|
5 |
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Cash Flows
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
Three Months
Ended March |
|
$ in millions |
|
|
2016 |
|
|
|
2015 |
|
Cash flows from operating activities |
|
|
|
|
|
|
|
|
Net earnings |
|
|
$ 1,135 |
|
|
|
$ 2,844 |
|
|
|
Adjustments to reconcile net earnings to net cash provided by/(used for) operating activities |
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
239 |
|
|
|
219 |
|
|
|
Share-based compensation |
|
|
1,665 |
|
|
|
1,809 |
|
|
|
Gain related to extinguishment of junior subordinated debt |
|
|
|
|
|
|
(34 |
) |
|
|
Changes in operating assets and liabilities |
|
|
|
|
|
|
|
|
Cash and securities segregated for regulatory and other purposes |
|
|
(1,449 |
) |
|
|
9,393 |
|
|
|
Receivables and payables (excluding loans receivable), net |
|
|
19 |
|
|
|
5,733 |
|
|
|
Collateralized transactions (excluding other secured financings), net |
|
|
(23,750 |
) |
|
|
7,546 |
|
|
|
Financial instruments owned, at fair value |
|
|
9,599 |
|
|
|
(13,266 |
) |
|
|
Financial instruments sold, but not yet purchased, at fair value |
|
|
11,697 |
|
|
|
726 |
|
|
|
Other, net |
|
|
(3,087 |
) |
|
|
(8,234 |
) |
Net cash provided by/(used for) operating activities |
|
|
(3,932 |
) |
|
|
6,736 |
|
|
|
Cash flows from investing activities |
|
|
|
|
|
|
|
|
Purchase of property, leasehold improvements and equipment |
|
|
(573 |
) |
|
|
(302 |
) |
|
|
Proceeds from sales of property, leasehold improvements and equipment |
|
|
210 |
|
|
|
13 |
|
|
|
Business acquisitions, net of cash acquired |
|
|
(562 |
) |
|
|
(477 |
) |
|
|
Proceeds from sales of investments |
|
|
322 |
|
|
|
184 |
|
|
|
Loans receivable, net |
|
|
(2,537 |
) |
|
|
(3,681 |
) |
Net cash used for investing activities |
|
|
(3,140 |
) |
|
|
(4,263 |
) |
|
|
Cash flows from financing activities |
|
|
|
|
|
|
|
|
Unsecured short-term borrowings, net |
|
|
1,970 |
|
|
|
(921 |
) |
|
|
Other secured financings (short-term), net |
|
|
775 |
|
|
|
(26 |
) |
|
|
Proceeds from issuance of other secured financings (long-term) |
|
|
933 |
|
|
|
4,293 |
|
|
|
Repayment of other secured financings (long-term), including the current portion |
|
|
(1,118 |
) |
|
|
(2,566 |
) |
|
|
Purchase of trust preferred securities |
|
|
|
|
|
|
(1 |
) |
|
|
Purchase of Automatic Preferred Enhanced Capital Securities (APEX) |
|
|
(505 |
) |
|
|
|
|
|
|
Proceeds from issuance of unsecured long-term borrowings |
|
|
14,752 |
|
|
|
11,873 |
|
|
|
Repayment of unsecured long-term borrowings, including the current portion |
|
|
(11,801 |
) |
|
|
(11,319 |
) |
|
|
Derivative contracts with a financing element, net |
|
|
16 |
|
|
|
(46 |
) |
|
|
Deposits, net |
|
|
7,347 |
|
|
|
3,046 |
|
|
|
Common stock repurchased |
|
|
(1,556 |
) |
|
|
(1,250 |
) |
|
|
Dividends and dividend equivalents paid on common stock, preferred stock and share-based awards |
|
|
(387 |
) |
|
|
(373 |
) |
|
|
Proceeds from issuance of preferred stock, net of issuance costs |
|
|
655 |
|
|
|
|
|
|
|
Proceeds from issuance of common stock, including exercise of share-based awards |
|
|
1 |
|
|
|
71 |
|
|
|
Excess tax benefit related to share-based awards |
|
|
54 |
|
|
|
275 |
|
Net cash provided by financing activities |
|
|
11,136 |
|
|
|
3,056 |
|
Net increase in cash and cash equivalents |
|
|
4,064 |
|
|
|
5,529 |
|
|
|
Cash and cash equivalents, beginning of year |
|
|
75,105 |
|
|
|
57,600 |
|
Cash and cash equivalents, end of period |
|
|
$ 79,169 |
|
|
|
$ 63,129 |
|
SUPPLEMENTAL DISCLOSURES:
Cash payments for interest, net of capitalized interest, were $2.25 billion and $1.77 billion and cash payments for income taxes, net of
refunds, were $266 million and $451 million during the three months ended March 2016 and March 2015, respectively.
Non-cash
activities during the three months ended March 2016:
The impact of adoption of ASU No. 2015-02 was a net reduction to both total assets
and liabilities of approximately $200 million. See Note 3 for further information.
The firm sold assets and liabilities of
$1.81 billion and $697 million, respectively, that were previously classified as held for sale, in exchange for $1.11 billion of financial instruments. See Notes 13 and 17 for further information.
The firm exchanged $505 million of APEX for $666 million of Series E and Series F Preferred Stock. See Note 19 for further
information.
Cash flows related to common stock repurchased includes common stock repurchased in the prior quarter for which settlement occurred
during the current quarter and excludes common stock repurchased during the current quarter for which settlement occurred in the following quarter.
Non-cash activities during the three months ended March 2015:
The firm exchanged $262 million of Trust Preferred Securities and common beneficial interests for $296 million of certain of the firms
junior subordinated debt.
The accompanying notes are an integral part of these condensed consolidated financial statements.
|
|
|
|
|
6 |
|
Goldman Sachs March 2016 Form 10-Q |
|
|
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Note 1.
Description of Business
The Goldman Sachs Group,
Inc. (Group Inc. or parent company), a Delaware corporation, together with its consolidated subsidiaries (collectively, the firm), is a leading global investment banking, securities and investment management firm that provides a wide range of
financial services to a substantial and diversified client base that includes corporations, financial institutions, governments and individuals. Founded in 1869, the firm is headquartered in New York and maintains offices in all major financial
centers around the world.
The firm reports its activities in the following four business segments:
Investment Banking
The firm provides a broad range
of investment banking services to a diverse group of corporations, financial institutions, investment funds and governments. Services include strategic advisory assignments with respect to mergers and acquisitions, divestitures, corporate defense
activities, restructurings, spin-offs and risk management, and debt and equity underwriting of public offerings and private placements, including local and cross-border transactions and acquisition financing, as well as derivative transactions
directly related to these activities.
Institutional Client Services
The firm facilitates client transactions and makes markets in fixed income, equity, currency and commodity products, primarily with
institutional clients such as corporations, financial institutions, investment funds and governments. The firm also makes markets in and clears client transactions on major stock, options and futures exchanges worldwide and provides financing,
securities lending and other prime brokerage services to institutional clients.
Investing & Lending
The firm invests in and originates loans to provide financing to clients. These investments and loans are typically longer-term in nature. The
firm makes investments, some of which are consolidated, directly and indirectly through funds and separate accounts that the firm manages, in debt securities and loans, public and private equity securities, and real estate entities.
Investment Management
The firm provides investment management services and offers investment products (primarily through separately managed accounts and commingled
vehicles, such as mutual funds and private investment funds) across all major asset classes to a diverse set of institutional and individual clients. The firm also offers wealth advisory services, including portfolio management and financial
counseling, and brokerage and other transaction services to high-net-worth individuals and families.
Note 2.
Basis of Presentation
These condensed consolidated
financial statements are prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) and include the accounts of Group Inc. and all other entities in which the firm has a controlling financial interest.
Intercompany transactions and balances have been eliminated.
These condensed consolidated financial statements are unaudited and should be
read in conjunction with the audited consolidated financial statements included in the firms Annual Report on Form 10-K for the year ended December 31, 2015. References to the 2015 Form 10-K are to the
firms Annual Report on Form 10-K for the year ended December 31, 2015. The condensed consolidated financial information as of December 31, 2015 has been derived from audited consolidated financial statements not
included herein.
These unaudited condensed consolidated financial statements reflect all adjustments that are, in the opinion of
management, necessary for a fair statement of the results for the interim periods presented. These adjustments are of a normal, recurring nature. Interim period operating results may not be indicative of the operating results for a full year.
All references to March 2016 and March 2015 refer to the firms periods ended, or the dates, as the context requires,
March 31, 2016 and March 31, 2015, respectively. All references to December 2015 refer to the date December 31, 2015. Any reference to a future year refers to a year ending on December 31 of that year. Certain
reclassifications have been made to previously reported amounts to conform to the current presentation.
|
|
|
|
|
|
|
Goldman Sachs March 2016 Form 10-Q |
|
7 |
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Note 3.
Significant Accounting Policies
The firms significant accounting policies include when and how to measure the fair value
of assets and liabilities, accounting for goodwill and identifiable intangible assets, and when to consolidate an entity. See Notes 5 through 8 for policies on fair value measurements, Note 13 for policies on goodwill and identifiable
intangible assets, and below and Note 12 for policies on consolidation accounting. All other significant accounting policies are either described below or included in the following footnotes:
|
|
|
|
|
|
|
Financial Instruments Owned, at Fair Value and Financial
Instruments Sold, But Not Yet Purchased, at Fair Value |
|
|
Note 4 |
|
|
|
Fair Value Measurements |
|
|
Note 5 |
|
|
|
Cash Instruments |
|
|
Note 6 |
|
|
|
Derivatives and Hedging Activities |
|
|
Note 7 |
|
|
|
Fair Value Option |
|
|
Note 8 |
|
|
|
Loans Receivable |
|
|
Note 9 |
|
|
|
Collateralized Agreements and Financings |
|
|
Note 10 |
|
|
|
Securitization Activities |
|
|
Note 11 |
|
|
|
Variable Interest Entities |
|
|
Note 12 |
|
|
|
Other Assets, including Goodwill and
Identifiable Intangible Assets |
|
|
Note 13 |
|
|
|
Deposits |
|
|
Note 14 |
|
|
|
Short-Term Borrowings |
|
|
Note 15 |
|
|
|
Long-Term Borrowings |
|
|
Note 16 |
|
|
|
Other Liabilities and Accrued Expenses |
|
|
Note 17 |
|
|
|
Commitments, Contingencies and Guarantees |
|
|
Note 18 |
|
|
|
Shareholders Equity |
|
|
Note 19 |
|
|
|
Regulation and Capital Adequacy |
|
|
Note 20 |
|
|
|
Earnings Per Common Share |
|
|
Note 21 |
|
|
|
Transactions with Affiliated Funds |
|
|
Note 22 |
|
|
|
Interest Income and Interest Expense |
|
|
Note 23 |
|
|
|
Income Taxes |
|
|
Note 24 |
|
|
|
Business Segments |
|
|
Note 25 |
|
|
|
Credit Concentrations |
|
|
Note 26 |
|
|
|
Legal Proceedings |
|
|
Note 27 |
|
Consolidation
The firm consolidates entities in which the firm has a controlling financial interest. The firm determines whether it has a controlling
financial interest in an entity by first evaluating whether the entity is a voting interest entity or a variable interest entity (VIE).
Voting Interest Entities. Voting interest entities are entities in which (i) the total equity investment at risk is sufficient to enable the entity to finance its
activities independently and (ii) the equity holders have the power to direct the activities of the entity that most significantly impact its economic performance, the obligation to absorb the losses of the entity and the right to receive the
residual returns of the entity. The usual condition for a controlling financial interest in a voting interest entity is ownership of a majority voting interest. If the firm has a controlling majority voting interest in a voting interest entity, the
entity is consolidated.
Variable Interest Entities. A VIE is an entity that lacks one or more of the characteristics of a voting interest entity. The firm has a controlling financial interest in a VIE when the firm has a variable interest or interests that provide
it with (i) the power to direct the activities of the VIE that most significantly impact the VIEs economic performance and (ii) the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could
potentially be significant to the VIE. See Note 12 for further information about VIEs.
Equity-Method Investments. When the firm does not have
a controlling financial interest in an entity but can exert significant influence over the entitys operating and financial policies, the investment is accounted for either (i) under the equity method of accounting or (ii) at fair
value by electing the fair value option available under U.S. GAAP. Significant influence generally exists when the firm owns 20% to 50% of the entitys common stock or in-substance common stock.
In general, the firm accounts for investments acquired after the fair value option became available, at fair value. In certain cases, the firm
applies the equity method of accounting to new investments that are strategic in nature or closely related to the firms principal business activities, when the firm has a significant degree of involvement in the cash flows or operations of the
investee or when cost-benefit considerations are less significant. See Note 13 for further information about equity-method investments.
|
|
|
|
|
8 |
|
Goldman Sachs March 2016 Form 10-Q |
|
|
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Investment Funds. The firm has formed numerous investment funds with third-party investors. These funds are typically organized as limited partnerships or limited liability companies for which the firm acts as general partner or
manager. Generally, the firm does not hold a majority of the economic interests in these funds. These funds are usually voting interest entities and generally are not consolidated because third-party investors typically have rights to terminate the
funds or to remove the firm as general partner or manager. Investments in these funds are included in Financial instruments owned, at fair value. See Notes 6, 18 and 22 for further information about investments in funds.
Use of Estimates
Preparation of these condensed
consolidated financial statements requires management to make certain estimates and assumptions, the most important of which relate to fair value measurements, accounting for goodwill and identifiable intangible assets, discretionary compensation
accruals, the provisions for losses that may arise from litigation, regulatory proceedings and tax audits, and the allowance for losses on loans and lending commitments held for investment. These estimates and assumptions are based on the best
available information but actual results could be materially different.
Revenue Recognition
Financial Assets and Financial Liabilities at Fair
Value. Financial instruments owned, at fair value and Financial instruments sold, but not yet purchased, at fair value are recorded at fair value either under the fair value option or in
accordance with other U.S. GAAP. In addition, the firm has elected to account for certain of its other financial assets and financial liabilities at fair value by electing the fair value option. The fair value of a financial instrument is the amount
that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets are marked to bid prices and financial liabilities are marked to offer prices.
Fair value measurements do not include transaction costs. Fair value gains or losses are generally included in Market making for positions in Institutional Client Services and Other principal transactions for positions in
Investing & Lending. See Notes 5 through 8 for further information about fair value measurements.
Investment Banking. Fees from financial advisory assignments and underwriting revenues are recognized in earnings when the services related to the underlying transaction are completed under the terms of the assignment. Expenses
associated with such transactions are deferred until the related revenue is recognized or the assignment is otherwise concluded. Expenses associated with financial advisory assignments are recorded as non-compensation expenses, net of client
reimbursements. Underwriting revenues are presented net of related expenses.
Investment
Management. The firm earns management fees and incentive fees for investment management services. Management fees for mutual funds are calculated as a percentage of daily net asset value and are
received monthly. Management fees for hedge funds and separately managed accounts are calculated as a percentage of month-end net asset value and are generally received quarterly. Management fees for private equity funds are calculated as a
percentage of monthly invested capital or commitments and are received quarterly, semi-annually or annually, depending on the fund. All management fees are recognized over the period that the related service is provided. Incentive fees are
calculated as a percentage of a funds or separately managed accounts return, or excess return above a specified benchmark or other performance target. Incentive fees are generally based on investment performance over a 12-month period or
over the life of a fund. Fees that are based on performance over a 12-month period are subject to adjustment prior to the end of the measurement period. For fees that are based on investment performance over the life of the fund, future investment
underperformance may require fees previously distributed to the firm to be returned to the fund. Incentive fees are recognized only when all material contingencies have been resolved. Management and incentive fee revenues are included in
Investment management revenues.
The firm makes payments to brokers and advisors related to the placement of the
firms investment funds. These payments are calculated based on either a percentage of the management fee or the investment funds net asset value. Where the firm is principal to the arrangement, such costs are recorded on a gross basis
and included in Brokerage, clearing, exchange and distribution fees, and where the firm is agent to the arrangement, such costs are recorded on a net basis in Investment management revenues.
|
|
|
|
|
|
|
Goldman Sachs March 2016 Form 10-Q |
|
9 |
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Commissions and Fees. The firm earns Commissions and fees from executing and clearing client transactions on stock, options and futures markets, as well as over-the-counter (OTC) transactions. Commissions and fees are
recognized on the day the trade is executed.
Transfers of Assets
Transfers of assets are accounted for as sales when the firm has relinquished control over the assets transferred. For transfers of assets
accounted for as sales, any gains or losses are recognized in net revenues. Assets or liabilities that arise from the firms continuing involvement with transferred assets are recognized at fair value. For transfers of assets that are not
accounted for as sales, the assets generally remain in Financial instruments owned, at fair value and the transfer is accounted for as a collateralized financing, with the related interest expense recognized over the life of the
transaction. See Note 10 for further information about transfers of assets accounted for as collateralized financings and Note 11 for further information about transfers of assets accounted for as sales.
Cash and Cash Equivalents
The firm defines cash
equivalents as highly liquid overnight deposits held in the ordinary course of business. As of March 2016 and December 2015, Cash and cash equivalents included $5.53 billion and $6.47 billion, respectively, of cash
and due from banks, and $73.64 billion and $68.64 billion, respectively, of interest-bearing deposits with banks.
Receivables from and
Payables to Brokers, Dealers and Clearing Organizations
Receivables from and payables to brokers, dealers and clearing organizations
are accounted for at cost plus accrued interest, which generally approximates fair value. While these receivables and payables are carried at amounts that approximate fair value, they are not accounted for at fair value under the fair value option
or at fair value in accordance with other U.S. GAAP and therefore are not included in the firms fair value hierarchy in Notes 6 through 8. Had these receivables and payables been included in the firms fair value hierarchy,
substantially all would have been classified in level 2 as of March 2016 and December 2015.
Receivables from Customers and Counterparties
Receivables from customers and counterparties generally relate to collateralized transactions. Such receivables are primarily comprised of
customer margin loans, certain transfers of assets accounted for as secured loans rather than purchases at fair value and collateral posted in connection with certain derivative transactions. Substantially all of these receivables are accounted for
at amortized cost net of estimated uncollectible amounts. Certain of the firms receivables from customers and counterparties are accounted for at fair value under the fair value option, with changes in fair value generally included in
Market making revenues. See Note 8 for further information about receivables from customers and counterparties accounted for at fair value under the fair value option. In addition, as of March 2016 and December 2015, the
firms receivables from customers and counterparties included $4.38 billion and $2.35 billion, respectively, of loans held for sale, accounted for at the lower of cost or fair value. See Note 5 for an overview of the firms
fair value measurement policies.
As of March 2016 and December 2015, the carrying value of receivables not accounted for at fair
value generally approximated fair value. While these items are carried at amounts that approximate fair value, they are not accounted for at fair value under the fair value option or at fair value in accordance with other U.S. GAAP and therefore are
not included in the firms fair value hierarchy in Notes 6 through 8. Had these items been included in the firms fair value hierarchy, substantially all would have been classified in level 2 as of March 2016 and
December 2015. Interest on receivables from customers and counterparties is recognized over the life of the transaction and included in Interest income.
Payables to Customers and Counterparties
Payables
to customers and counterparties primarily consist of customer credit balances related to the firms prime brokerage activities. Payables to customers and counterparties are accounted for at cost plus accrued interest, which generally
approximates fair value. While these payables are carried at amounts that approximate fair value, they are not accounted for at fair value under the fair value option or at fair value in accordance with other U.S. GAAP and therefore are not included
in the firms fair value hierarchy in Notes 6 through 8. Had these payables been included in the firms fair value hierarchy, substantially all would have been classified in level 2 as of March 2016 and December 2015.
Interest on payables to customers and counterparties is recognized over the life of the transaction and included in Interest expense.
|
|
|
|
|
10 |
|
Goldman Sachs March 2016 Form 10-Q |
|
|
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Offsetting Assets and Liabilities
To reduce credit exposures on derivatives and securities financing transactions, the firm may enter into master netting agreements or similar
arrangements (collectively, netting agreements) with counterparties that permit it to offset receivables and payables with such counterparties. A netting agreement is a contract with a counterparty that permits net settlement of multiple
transactions with that counterparty, including upon the exercise of termination rights by a non-defaulting party. Upon exercise of such termination rights, all transactions governed by the netting agreement are terminated and a net settlement amount
is calculated. In addition, the firm receives and posts cash and securities collateral with respect to its derivatives and securities financing transactions, subject to the terms of the related credit support agreements or similar arrangements
(collectively, credit support agreements). An enforceable credit support agreement grants the non-defaulting party exercising termination rights the right to liquidate the collateral and apply the proceeds to any amounts owed. In order to assess
enforceability of the firms right of setoff under netting and credit support agreements, the firm evaluates various factors including applicable bankruptcy laws, local statutes and regulatory provisions in the jurisdiction of the parties to
the agreement.
Derivatives are reported on a net-by-counterparty basis (i.e., the net payable or receivable for derivative assets and
liabilities for a given counterparty) in the condensed consolidated statements of financial condition when a legal right of setoff exists under an enforceable netting agreement. Resale and repurchase agreements and securities borrowed and loaned
transactions with the same term and currency are presented on a net-by-counterparty basis in the condensed consolidated statements of financial condition when such transactions meet certain settlement criteria and are subject to netting agreements.
In the condensed consolidated statements of financial condition, derivatives are reported net of cash collateral received and posted under
enforceable credit support agreements, when transacted under an enforceable netting agreement. In the condensed consolidated statements of financial condition, resale and repurchase agreements, and securities borrowed and loaned, are not
reported net of the related cash and securities received or posted as collateral. See Note 10 for further information about collateral received and pledged, including rights to deliver or repledge collateral. See Notes 7 and 10 for further
information about offsetting.
Share-based Compensation
The cost of employee services received in exchange for a share-based award is generally measured based on the grant-date fair value of the
award. Share-based awards that do not require future service (i.e., vested awards, including awards granted to retirement-eligible employees) are expensed immediately. Share-based awards that require future service are amortized over the relevant
service period. Expected forfeitures are included in determining share-based employee compensation expense.
The firm pays cash dividend
equivalents on outstanding restricted stock units (RSUs). Dividend equivalents paid on RSUs are generally charged to retained earnings. Dividend equivalents paid on RSUs expected to be forfeited are included in compensation expense. The firm
accounts for the tax benefit related to dividend equivalents paid on RSUs as an increase to additional paid-in capital.
The firm generally
issues new shares of common stock upon delivery of share-based awards. In certain cases, primarily related to conflicted employment (as outlined in the applicable award agreements), the firm may cash settle share-based compensation awards accounted
for as equity instruments. For these awards, whose terms allow for cash settlement, additional paid-in capital is adjusted to the extent of the difference between the value of the award at the time of cash settlement and the grant-date value of the
award.
Foreign Currency Translation
Assets and
liabilities denominated in non-U.S. currencies are translated at rates of exchange prevailing on the date of the condensed consolidated statements of financial condition and revenues and expenses are translated at average rates of exchange for the
period. Foreign currency remeasurement gains or losses on transactions in nonfunctional currencies are recognized in earnings. Gains or losses on translation of the financial statements of a non-U.S. operation, when the functional currency is other
than the U.S. dollar, are included, net of hedges and taxes, in the condensed consolidated statements of comprehensive income.
|
|
|
|
|
|
|
Goldman Sachs March 2016 Form 10-Q |
|
11 |
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Recent Accounting Developments
Revenue from Contracts with Customers
(ASC 606). In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606). ASU No. 2014-09 provides comprehensive guidance on
the recognition of revenue from customers arising from the transfer of goods and services. The ASU also provides guidance on accounting for certain contract costs, and requires new disclosures. ASU No. 2014-09, as amended by ASU
No. 2015-14, ASU No. 2016-08 and ASU No. 2016-10, is effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period. Early adoption is permitted for annual
reporting periods beginning after December 15, 2016. The firm is still evaluating the effect of the ASU on its financial condition, results of operations, and cash flows.
Measuring the Financial Assets and the Financial Liabilities of a Consolidated Collateralized Financing
Entity (ASC 810). In August 2014, the FASB issued ASU No. 2014-13, Consolidation (Topic 810) Measuring the Financial Assets and the Financial Liabilities of a
Consolidated Collateralized Financing Entity (CFE). ASU No. 2014-13 provides an alternative to reflect changes in the fair value of the financial assets and the financial liabilities of the CFE by measuring either the fair value of the
assets or liabilities, whichever is more observable. ASU No. 2014-13 provides new disclosure requirements for those electing this approach, and was effective for interim and annual periods beginning after
December 15, 2015. Adoption of ASU No. 2014-13 did not materially affect the firms financial condition, results of operations, or cash flows.
Amendments to the Consolidation Analysis
(ASC 810). In February 2015, the FASB issued ASU No. 2015-02, Consolidation (Topic 810) Amendments to the Consolidation Analysis. ASU
No. 2015-02 eliminates the deferral of the requirements of ASU No. 2009-17, Consolidations (Topic 810) Improvements to Financial Reporting by Enterprises Involved with Variable Interest Entities for certain
interests in investment funds and provides a scope exception from Topic 810 for certain investments in money market funds. The ASU also makes several modifications to the consolidation guidance for VIEs and general partners investments in
limited partnerships, as well as modifications to the evaluation of whether limited partnerships are VIEs or voting interest entities. ASU No. 2015-02 is effective for interim and annual reporting periods beginning after
December 15, 2015 and is required to be adopted under a modified retrospective approach or retrospectively to all periods presented.
The firm adopted ASU No. 2015-02 as of January 1, 2016, using a modified
retrospective approach. The impact of adoption was a net reduction to both total assets and total liabilities of approximately $200 million, substantially all included in Financial instruments owned, at fair value and in Other
liabilities and accrued expenses, respectively. Adoption of ASU No. 2015-02 did not have an impact on the firms results of operations. See Note 12 for further information about the adoption of ASU No. 2015-02.
Simplifying the Presentation of Debt Issuance Costs (ASC 835). In April 2015, the FASB issued ASU No. 2015-03, Interest Imputation of Interest (Subtopic 835-30) Simplifying the Presentation of Debt Issuance Costs. ASU No. 2015-03
simplifies the presentation of debt issuance costs by requiring that these costs related to a recognized debt liability be presented in the statements of financial condition as a direct reduction from the carrying amount of that liability. ASU
No. 2015-03 is effective for annual reporting periods beginning after December 15, 2015, including interim periods within that reporting period. ASU No. 2015-03 is required to be applied retrospectively to all periods presented
beginning in the year of adoption. Early adoption was permitted. The firm early adopted ASU No. 2015-03 in September 2015. In accordance with ASU No. 2015-03, previously reported amounts have been conformed to the current
presentation.
Simplifying the Accounting for Measurement-Period Adjustments
(ASC 805). In September 2015, the FASB issued ASU No. 2015-16, Business Combinations (Topic 805) Simplifying the Accounting for Measurement-Period
Adjustments. ASU No. 2015-16 eliminates the requirement for an acquirer in a business combination to account for measurement-period adjustments retrospectively. ASU No. 2015-16 was effective for annual reporting periods beginning
after December 15, 2015, including interim periods within that reporting period. Adoption of ASU No. 2015-16 did not materially affect the firms financial condition, results of operations, or cash flows.
|
|
|
|
|
12 |
|
Goldman Sachs March 2016 Form 10-Q |
|
|
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Disclosures for Investments in Certain Entities That
Calculate Net Asset Value (NAV) per Share (or Its Equivalent) (ASC 820). In May 2015, the FASB issued ASU No. 201507, Fair Value Measurement (Topic 820)
Disclosures for Investments in Certain Entities That Calculate Net Asset Value per Share (or Its Equivalent). ASU No. 201507 requires that investments for which the fair value is measured at NAV using the practical expedient
(investments in funds measured at NAV) under Fair Value Measurements and Disclosures (Topic 820) be excluded from the fair value hierarchy. ASU No. 201507 is effective for annual reporting periods beginning after
December 15, 2015, including interim periods within that reporting period. ASU No. 201507 is required to be applied retrospectively to all periods presented beginning in the period of adoption. Early adoption was permitted. The
firm early adopted ASU No. 201507 in June 2015 and adoption did not affect the firms financial condition, results of operations, or cash flows. In accordance with ASU No. 2015-07, previously reported amounts have been
conformed to the current presentation. See Notes 4 through 6 for the disclosures required by ASU No. 2015-07.
Recognition and Measurement of Financial Assets and Financial Liabilities (ASC 825). In January 2016, the FASB issued ASU No. 2016-01, Financial
Instruments (Topic 825) Recognition and Measurement of Financial Assets and Financial Liabilities. ASU No. 2016-01 amends certain aspects of recognition, measurement, presentation and disclosure of financial instruments. This
guidance includes a requirement to present separately in other comprehensive income changes in fair value attributable to a firms own credit spreads (debt valuation adjustment or DVA), net of tax, on financial liabilities for which the fair
value option was elected. ASU No. 2016-01 is effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period. Early adoption is permitted under a modified retrospective
approach for the requirements related to DVA. In the first quarter of 2016, the firm early adopted ASU No. 2016-01 for the requirements related to DVA, and reclassified the cumulative DVA, a gain of $305 million (net of tax), from retained
earnings to accumulated other comprehensive loss.
Leases (ASC 842). In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842). ASU No. 2016-02 requires that, at lease inception, a lessee recognize in the statements of financial condition
a right-of-use asset, representing the right to use the underlying asset for the lease term, and a lease liability, representing the liability to make lease payments. The ASU also requires that for finance leases, a lessee recognize interest expense
on the lease liability, separately from the amortization of the right-of-use asset in the statements of earnings, while for operating leases, such amounts should be recognized as a combined expense in the statements of earnings. In addition, ASU
No. 2016-02 requires expanded disclosures about the nature and terms of lease agreements and is effective for annual reporting periods beginning after December 15, 2018, including interim periods within that reporting period. Early
adoption is permitted. The firm is still evaluating the effect of the ASU on its financial condition, results of operations, and cash flows.
Improvements to Employee Share-Based Payment Accounting (ASC 718). In March 2016, the FASB issued ASU No. 2016-09, Compensation Stock Compensation (Topic 718) Improvements to Employee Share-Based Payment Accounting. ASU
No. 2016-09 includes provisions to simplify certain aspects related to the accounting for share-based awards and the related financial statement presentation. This ASU includes a requirement that the tax effect related to the settlement of
share-based awards be recorded in income tax benefit or expense in the statements of earnings. This change is required to be adopted prospectively in the period of adoption. In addition, the ASU modifies the classification of certain share-based
payment activities within the statements of cash flows and these changes are required to be applied retrospectively to all periods presented, or in certain cases prospectively, beginning in the period of adoption. ASU No. 2016-09 is effective
for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early adoption is permitted. The impact of ASU No. 2016-09 could be material to the results of operations and cash
flows in future periods depending upon, among other things, the level of earnings and stock price of the firm.
|
|
|
|
|
|
|
Goldman Sachs March 2016 Form 10-Q |
|
13 |
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
|
|
|
|
|
Note 4.
Financial Instruments Owned, at Fair Value and Financial Instruments Sold, But Not Yet Purchased, at Fair Value |
|
|
|
|
Financial instruments owned, at fair value and financial instruments sold, but not yet
purchased, at fair value are accounted for at fair value either under the fair value option or in accordance with other U.S. GAAP. See Note 8 for further information about other financial assets and financial liabilities accounted for at fair
value primarily under the fair value option.
The table below presents the firms financial instruments owned, at fair value, and
financial instruments sold, but not yet purchased, at fair value.
|
|
|
|
|
|
|
|
|
$ in millions |
|
|
Financial Instruments Owned |
|
|
|
Financial Instruments Sold, But Not Yet Purchased |
|
As of March 2016 |
|
|
|
|
|
|
|
|
Commercial paper, certificates of deposit, time deposits and other money market instruments |
|
|
$ 1,878 |
|
|
|
$ |
|
|
|
U.S. government and federal agency obligations |
|
|
46,716 |
|
|
|
12,453 |
|
|
|
Non-U.S. government and agency obligations |
|
|
34,627 |
|
|
|
17,539 |
|
|
|
Loans and securities backed by commercial real estate |
|
|
5,555 |
|
|
|
2 |
|
|
|
Loans and securities backed by residential real estate |
|
|
12,196 |
|
|
|
1 |
|
|
|
Bank loans and bridge loans |
|
|
11,292 |
|
|
|
557 |
|
|
|
Corporate debt securities |
|
|
17,108 |
|
|
|
7,678 |
|
|
|
State and municipal obligations |
|
|
1,169 |
|
|
|
|
|
|
|
Other debt obligations |
|
|
1,361 |
|
|
|
2 |
|
|
|
Equities and convertible debentures |
|
|
81,912 |
|
|
|
34,598 |
|
|
|
Commodities |
|
|
5,240 |
|
|
|
|
|
|
|
Investments in funds measured at NAV |
|
|
7,177 |
|
|
|
|
|
Subtotal |
|
|
226,231 |
|
|
|
72,830 |
|
|
|
Derivatives |
|
|
60,671 |
|
|
|
54,183 |
|
Total |
|
|
$286,902 |
|
|
|
$127,013 |
|
As of December 2015 |
|
|
|
|
|
|
|
|
Commercial paper, certificates of deposit, time deposits and other money market instruments |
|
|
$ 2,583 |
|
|
|
$ |
|
|
|
U.S. government and federal agency obligations |
|
|
46,382 |
|
|
|
15,516 |
|
|
|
Non-U.S. government and agency obligations |
|
|
31,772 |
|
|
|
14,973 |
|
|
|
Loans and securities backed by commercial real estate |
|
|
4,975 |
|
|
|
4 |
|
|
|
Loans and securities backed by residential real estate |
|
|
13,183 |
|
|
|
2 |
|
|
|
Bank loans and bridge loans |
|
|
12,164 |
|
|
|
461 |
|
|
|
Corporate debt securities |
|
|
16,640 |
|
|
|
6,123 |
|
|
|
State and municipal obligations |
|
|
992 |
|
|
|
2 |
|
|
|
Other debt obligations |
|
|
1,595 |
|
|
|
2 |
|
|
|
Equities and convertible debentures |
|
|
98,072 |
|
|
|
31,394 |
|
|
|
Commodities |
|
|
3,935 |
|
|
|
|
|
|
|
Investments in funds measured at NAV |
|
|
7,757 |
|
|
|
|
|
Subtotal |
|
|
240,050 |
|
|
|
68,477 |
|
|
|
Derivatives |
|
|
53,890 |
|
|
|
46,771 |
|
Total |
|
|
$293,940 |
|
|
|
$115,248 |
|
Gains and Losses from Market Making and Other Principal Transactions
The table below presents Market making revenues by major product type, as well as Other principal transactions
revenues.
|
|
|
|
|
|
|
|
|
$ in millions
Product Type |
|
Three Months
Ended March |
|
|
|
2016 |
|
|
|
2015 |
|
Interest rates |
|
|
$1,177 |
|
|
|
$(2,586 |
) |
|
|
Credit |
|
|
618 |
|
|
|
932 |
|
|
|
Currencies |
|
|
(908 |
) |
|
|
3,652 |
|
|
|
Equities |
|
|
691 |
|
|
|
1,662 |
|
|
|
Commodities |
|
|
284 |
|
|
|
265 |
|
Market making |
|
|
1,862 |
|
|
|
3,925 |
|
Other principal transactions |
|
|
(49 |
) |
|
|
1,572 |
|
Total |
|
|
$1,813 |
|
|
|
$ 5,497 |
|
In the table above:
|
|
Gains/(losses) include both realized and unrealized gains and losses, and are primarily related to the
firms financial instruments owned, at fair value and financial instruments sold, but not yet purchased, at fair value, including both derivative and non-derivative financial instruments. |
|
|
Gains/(losses) exclude related interest income and interest expense. See Note 23 for further information
about interest income and interest expense. |
|
|
Gains/(losses) on other principal transactions are included in the firms Investing & Lending
segment. See Note 25 for net revenues, including net interest income, by product type for Investing & Lending, as well as the amount of net interest income included in Investing & Lending. |
|
|
Gains/(losses) are not representative of the manner in which the firm manages its business activities because
many of the firms market-making and client facilitation strategies utilize financial instruments across various product types. Accordingly, gains or losses in one product type frequently offset gains or losses in other product types. For
example, most of the firms longer-term derivatives across product types are sensitive to changes in interest rates and may be economically hedged with interest rate swaps. Similarly, a significant portion of the firms cash instruments
and derivatives across product types has exposure to foreign currencies and may be economically hedged with foreign currency contracts.
|
|
|
|
|
|
14 |
|
Goldman Sachs March 2016 Form 10-Q |
|
|
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Note 5.
Fair Value Measurements
The fair value of a financial instrument is the amount that would be received to sell an asset
or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets are marked to bid prices and financial liabilities are marked to offer prices. Fair value measurements do not include
transaction costs. The firm measures certain financial assets and financial liabilities as a portfolio (i.e., based on its net exposure to market and/or credit risks).
The best evidence of fair value is a quoted price in an active market. If quoted prices in active markets are not available, fair value is
determined by reference to prices for similar instruments, quoted prices or recent transactions in less active markets, or internally developed models that primarily use market-based or independently sourced parameters as inputs including, but not
limited to, interest rates, volatilities, equity or debt prices, foreign exchange rates, commodity prices, credit spreads and funding spreads (i.e., the spread, or difference, between the interest rate at which a borrower could finance a given
financial instrument relative to a benchmark interest rate).
U.S. GAAP has a three-level fair value hierarchy for disclosure of fair value
measurements. The fair value hierarchy prioritizes inputs to the valuation techniques used to measure fair value, giving the highest priority to level 1 inputs and the lowest priority to level 3 inputs. A financial instruments level
in the fair value hierarchy is based on the lowest level of input that is significant to its fair value measurement. The fair value hierarchy is as follows:
Level 1. Inputs are unadjusted quoted prices in
active markets to which the firm had access at the measurement date for identical, unrestricted assets or liabilities.
Level 2. Inputs to valuation techniques are observable, either directly or indirectly.
Level 3. One or more inputs to valuation
techniques are significant and unobservable.
The fair values for substantially all of the firms financial assets and
financial liabilities are based on observable prices and inputs and are classified in levels 1 and 2 of the fair value hierarchy. Certain level 2 and level 3 financial assets and financial liabilities may require appropriate valuation
adjustments that a market participant would require to arrive at fair value for factors such as counterparty and the firms credit quality, funding risk, transfer restrictions, liquidity and bid/offer spreads. Valuation adjustments are
generally based on market evidence.
See Notes 6 through 8 for further information about fair value measurements of cash
instruments, derivatives and other financial assets and financial liabilities accounted for at fair value primarily under the fair value option (including information about unrealized gains and losses related to level 3 financial assets and
financial liabilities, and transfers in and out of level 3), respectively.
The table below presents financial assets and financial
liabilities accounted for at fair value under the fair value option or in accordance with other U.S. GAAP. Counterparty and cash collateral netting represents the impact on derivatives of netting across levels of the fair value hierarchy. Netting
among positions classified in the same level is included in that level.
|
|
|
|
|
|
|
|
|
|
|
As of |
|
$ in millions |
|
|
March 2016 |
|
|
|
December 2015 |
|
Total level 1 financial assets |
|
|
$136,833 |
|
|
|
$153,051 |
|
|
|
Total level 2 financial assets |
|
|
450,629 |
|
|
|
432,445 |
|
|
|
Total level 3 financial assets |
|
|
24,462 |
|
|
|
24,046 |
|
|
|
Investments in funds measured at NAV |
|
|
7,177 |
|
|
|
7,757 |
|
|
|
Counterparty and cash collateral netting |
|
|
(95,400 |
) |
|
|
(90,612 |
) |
Total financial assets at fair value |
|
|
$523,701 |
|
|
|
$526,687 |
|
Total assets 1 |
|
|
$878,036 |
|
|
|
$861,395 |
|
|
|
Total level 3 financial assets as a percentage of total assets |
|
|
2.8% |
|
|
|
2.8% |
|
|
|
Total level 3 financial assets as a percentage of total
financial assets at fair value |
|
|
4.7% |
|
|
|
4.6% |
|
Total level 1 financial liabilities |
|
|
$ 62,777 |
|
|
|
$ 59,798 |
|
|
|
Total level 2 financial liabilities |
|
|
257,286 |
|
|
|
245,759 |
|
|
|
Total level 3 financial liabilities |
|
|
19,683 |
|
|
|
16,812 |
|
|
|
Counterparty and cash collateral netting |
|
|
(49,223 |
) |
|
|
(41,430 |
) |
Total financial liabilities at fair value |
|
|
$290,523 |
|
|
|
$280,939 |
|
|
|
Total level 3 financial liabilities as a percentage of total
financial liabilities at fair value |
|
|
6.8% |
|
|
|
6.0% |
|
1. |
Includes $854 billion and $836 billion as of March 2016 and December 2015, respectively, that is
carried at fair value or at amounts that generally approximate fair value. |
The table below presents a summary of
level 3 financial assets. See Notes 6 through 8 for further information about level 3 financial assets.
|
|
|
|
|
|
|
|
|
|
|
As of |
|
$ in millions |
|
|
March 2016 |
|
|
|
December 2015 |
|
Cash instruments |
|
|
$ 18,469 |
|
|
|
$ 18,131 |
|
|
|
Derivatives |
|
|
5,950 |
|
|
|
5,870 |
|
|
|
Other financial assets |
|
|
43 |
|
|
|
45 |
|
Total |
|
|
$ 24,462 |
|
|
|
$ 24,046 |
|
Level 3 financial assets as of March 2016 were essentially unchanged compared with
December 2015.
|
|
|
|
|
|
|
Goldman Sachs March 2016 Form 10-Q |
|
15 |
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Note 6.
Cash Instruments
Cash instruments include U.S. government and federal agency obligations, non-U.S. government and
agency obligations, mortgage-backed loans and securities, bank loans and bridge loans, corporate debt securities, equities and convertible debentures, investments in funds measured at NAV, and other non-derivative financial instruments owned and
financial instruments sold, but not yet purchased. See below for the types of cash instruments included in each level of the fair value hierarchy and the valuation techniques and significant inputs used to determine their fair values. See
Note 5 for an overview of the firms fair value measurement policies.
Level 1 Cash Instruments
Level 1 cash instruments include U.S. government obligations and most non-U.S. government obligations, actively traded listed equities,
certain government agency obligations and money market instruments. These instruments are valued using quoted prices for identical unrestricted instruments in active markets.
The firm defines active markets for equity instruments based on the average daily trading volume both in absolute terms and relative to the
market capitalization for the instrument. The firm defines active markets for debt instruments based on both the average daily trading volume and the number of days with trading activity.
Level 2 Cash Instruments
Level 2 cash
instruments include commercial paper, certificates of deposit, time deposits, most government agency obligations, certain non-U.S. government obligations, most corporate debt securities, commodities, certain mortgage-backed loans and securities,
certain bank loans and bridge loans, restricted or less liquid listed equities, most state and municipal obligations and certain lending commitments.
Valuations of level 2 cash instruments can be verified to quoted prices, recent trading activity for identical or similar instruments,
broker or dealer quotations or alternative pricing sources with reasonable levels of price transparency. Consideration is given to the nature of the quotations (e.g., indicative or firm) and the relationship of recent market activity to the prices
provided from alternative pricing sources.
Valuation adjustments are typically made to level 2 cash instruments (i) if the cash
instrument is subject to transfer restrictions and/or (ii) for other premiums and liquidity discounts that a market participant would require to arrive at fair value. Valuation adjustments are generally based on market evidence.
Level 3 Cash Instruments
Level 3 cash
instruments have one or more significant valuation inputs that are not observable. Absent evidence to the contrary, level 3 cash instruments are initially valued at transaction price, which is considered to be the best initial estimate of fair
value. Subsequently, the firm uses other methodologies to determine fair value, which vary based on the type of instrument. Valuation inputs and assumptions are changed when corroborated by substantive observable evidence, including values realized
on sales of financial assets.
Valuation Techniques and Significant Inputs of Level 3 Cash Instruments
Valuation techniques of level 3 cash instruments vary by instrument, but are generally based on discounted cash flow techniques. The
valuation techniques and the nature of significant inputs used to determine the fair values of each type of level 3 cash instrument are described below:
Loans and Securities Backed by Commercial Real Estate.
Loans and securities backed by commercial real estate are directly or indirectly collateralized by a single commercial real estate property or a portfolio of properties, and may include tranches
of varying levels of subordination. Significant inputs are generally determined based on relative value analyses and include:
|
|
Transaction prices in both the underlying collateral and instruments with the same or similar underlying
collateral and the basis, or price difference, to such prices; |
|
|
Market yields implied by transactions of similar or related assets and/or current levels and changes in market
indices such as the CMBX (an index that tracks the performance of commercial mortgage bonds); |
|
|
|
|
|
16 |
|
Goldman Sachs March 2016 Form 10-Q |
|
|
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
|
|
A measure of expected future cash flows in a default scenario (recovery rates) implied by the value of the
underlying collateral, which is mainly driven by current performance of the underlying collateral, capitalization rates and multiples. Recovery rates are expressed as a percentage of notional or face value of the instrument and reflect the benefit
of credit enhancements on certain instruments; and |
|
|
Timing of expected future cash flows (duration) which, in certain cases, may incorporate the impact of other
unobservable inputs (e.g., prepayment speeds). |
Loans and Securities Backed by
Residential Real Estate. Loans and securities backed by residential real estate are directly or indirectly collateralized by portfolios of residential real estate and may include tranches of
varying levels of subordination. Significant inputs are generally determined based on relative value analyses, which incorporate comparisons to instruments with similar collateral and risk profiles. Significant inputs include:
|
|
Transaction prices in both the underlying collateral and instruments with the same or similar underlying
collateral; |
|
|
Market yields implied by transactions of similar or related assets; |
|
|
Cumulative loss expectations, driven by default rates, home price projections, residential property
liquidation timelines, related costs and subsequent recoveries; and |
|
|
Duration, driven by underlying loan prepayment speeds and residential property liquidation timelines.
|
Bank Loans and Bridge Loans.
Significant inputs are generally determined based on relative value analyses, which incorporate comparisons both to prices of credit default swaps that reference the same or similar underlying instrument or entity and to other debt instruments for
the same issuer for which observable prices or broker quotations are available. Significant inputs include:
|
|
Market yields implied by transactions of similar or related assets and/or current levels and trends of market
indices such as CDX and LCDX (indices that track the performance of corporate credit and loans, respectively); |
|
|
Current performance and recovery assumptions and, where the firm uses credit default swaps to value the
related cash instrument, the cost of borrowing the underlying reference obligation; and |
Equities and Convertible Debentures (Including Private Equity
Investments and Investments in Real Estate Entities). Recent third-party completed or pending transactions (e.g., merger proposals, tender offers, debt restructurings) are considered to be the
best evidence for any change in fair value. When these are not available, the following valuation methodologies are used, as appropriate:
|
|
Industry multiples (primarily EBITDA multiples) and public comparables; |
|
|
Transactions in similar instruments; |
|
|
Discounted cash flow techniques; and |
|
|
Third-party appraisals. |
The firm also considers changes in the outlook for the relevant industry and financial performance of the issuer as compared to projected
performance. Significant inputs include:
|
|
Market and transaction multiples; |
|
|
Discount rates, long-term growth rates, earnings compound annual growth rates and capitalization rates; and
|
|
|
For equity instruments with debt-like features, market yields implied by transactions of similar or related
assets, current performance and recovery assumptions, and duration. |
Other Cash
Instruments. Other cash instruments consists of commercial paper, certificates of deposit, time deposits and other money market instruments; non-U.S. government and agency obligations; corporate
debt securities; state and municipal obligations; and other debt obligations. Significant inputs are generally determined based on relative value analyses, which incorporate comparisons both to prices of credit default swaps that reference the same
or similar underlying instrument or entity and to other debt instruments for the same issuer for which observable prices or broker quotations are available. Significant inputs include:
|
|
Market yields implied by transactions of similar or related assets and/or current levels and trends of market
indices such as CDX and LCDX; |
|
|
Current performance and recovery assumptions and, where the firm uses credit default swaps to value the
related cash instrument, the cost of borrowing the underlying reference obligation; and |
|
|
|
|
|
|
|
Goldman Sachs March 2016 Form 10-Q |
|
17 |
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Fair Value of Cash Instruments by Level
The tables below present cash instrument assets and liabilities at fair value by level within
the fair value hierarchy. In the tables below:
|
|
Cash instrument assets and liabilities are included in Financial instruments owned, at fair value
and Financial instruments sold, but not yet purchased, at fair value, respectively. |
|
|
Cash instrument assets are shown as positive amounts and cash instrument liabilities are shown as negative
amounts. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of March 2016 |
|
$ in millions |
|
|
Level 1 |
|
|
|
Level 2 |
|
|
|
Level 3 |
|
|
|
Total |
|
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial paper, certificates of deposit, time deposits and other money market instruments |
|
|
$ 262 |
|
|
|
$ 1,616 |
|
|
|
$ |
|
|
|
$ 1,878 |
|
|
|
U.S. government and federal agency obligations |
|
|
24,242 |
|
|
|
22,474 |
|
|
|
|
|
|
|
46,716 |
|
|
|
Non-U.S. government and agency obligations |
|
|
28,797 |
|
|
|
5,772 |
|
|
|
58 |
|
|
|
34,627 |
|
|
|
Loans and securities backed by commercial real estate |
|
|
|
|
|
|
3,387 |
|
|
|
2,168 |
|
|
|
5,555 |
|
|
|
Loans and securities backed by residential real estate |
|
|
|
|
|
|
10,762 |
|
|
|
1,434 |
|
|
|
12,196 |
|
|
|
Bank loans and bridge loans |
|
|
|
|
|
|
8,103 |
|
|
|
3,189 |
|
|
|
11,292 |
|
|
|
Corporate debt securities |
|
|
185 |
|
|
|
14,321 |
|
|
|
2,602 |
|
|
|
17,108 |
|
|
|
State and municipal obligations |
|
|
|
|
|
|
1,083 |
|
|
|
86 |
|
|
|
1,169 |
|
|
|
Other debt obligations |
|
|
|
|
|
|
903 |
|
|
|
458 |
|
|
|
1,361 |
|
|
|
Equities and convertible debentures |
|
|
65,439 |
|
|
|
7,999 |
|
|
|
8,474 |
|
|
|
81,912 |
|
|
|
Commodities |
|
|
|
|
|
|
5,240 |
|
|
|
|
|
|
|
5,240 |
|
Subtotal |
|
|
$118,925 |
|
|
|
$81,660 |
|
|
|
$18,469 |
|
|
|
$219,054 |
|
|
|
Investments in funds measured at NAV |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,177 |
|
Total cash instrument assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$226,231 |
|
Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. government and federal agency obligations |
|
|
$(12,444 |
) |
|
|
$ (9 |
) |
|
|
$ |
|
|
|
$ (12,453 |
) |
|
|
Non-U.S. government and agency obligations |
|
|
(16,078 |
) |
|
|
(1,461 |
) |
|
|
|
|
|
|
(17,539 |
) |
|
|
Loans and securities backed by commercial real estate |
|
|
|
|
|
|
(1 |
) |
|
|
(1 |
) |
|
|
(2 |
) |
|
|
Loans and securities backed by residential real estate |
|
|
|
|
|
|
(1 |
) |
|
|
|
|
|
|
(1 |
) |
|
|
Bank loans and bridge loans |
|
|
|
|
|
|
(464 |
) |
|
|
(93 |
) |
|
|
(557 |
) |
|
|
Corporate debt securities |
|
|
(9 |
) |
|
|
(7,665 |
) |
|
|
(4 |
) |
|
|
(7,678 |
) |
|
|
Other debt obligations |
|
|
|
|
|
|
(1 |
) |
|
|
(1 |
) |
|
|
(2 |
) |
|
|
Equities and convertible debentures |
|
|
(34,221 |
) |
|
|
(338 |
) |
|
|
(39 |
) |
|
|
(34,598 |
) |
Total cash instrument liabilities |
|
|
$(62,752 |
) |
|
|
$ (9,940 |
) |
|
|
$ (138 |
) |
|
|
$(72,830 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 2015 |
|
$ in millions |
|
|
Level 1 |
|
|
|
Level 2 |
|
|
|
Level 3 |
|
|
|
Total |
|
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial paper, certificates of deposit, time deposits and other
money market instruments |
|
|
$ 625 |
|
|
|
$ 1,958 |
|
|
|
$ |
|
|
|
$ 2,583 |
|
|
|
U.S. government and federal agency obligations |
|
|
24,844 |
|
|
|
21,538 |
|
|
|
|
|
|
|
46,382 |
|
|
|
Non-U.S. government and agency obligations |
|
|
26,500 |
|
|
|
5,260 |
|
|
|
12 |
|
|
|
31,772 |
|
|
|
Loans and securities backed by commercial real estate |
|
|
|
|
|
|
3,051 |
|
|
|
1,924 |
|
|
|
4,975 |
|
|
|
Loans and securities backed by residential real estate |
|
|
|
|
|
|
11,418 |
|
|
|
1,765 |
|
|
|
13,183 |
|
|
|
Bank loans and bridge loans |
|
|
|
|
|
|
9,014 |
|
|
|
3,150 |
|
|
|
12,164 |
|
|
|
Corporate debt securities |
|
|
218 |
|
|
|
14,330 |
|
|
|
2,092 |
|
|
|
16,640 |
|
|
|
State and municipal obligations |
|
|
|
|
|
|
891 |
|
|
|
101 |
|
|
|
992 |
|
|
|
Other debt obligations |
|
|
|
|
|
|
1,057 |
|
|
|
538 |
|
|
|
1,595 |
|
|
|
Equities and convertible debentures |
|
|
81,252 |
|
|
|
8,271 |
|
|
|
8,549 |
|
|
|
98,072 |
|
|
|
Commodities |
|
|
|
|
|
|
3,935 |
|
|
|
|
|
|
|
3,935 |
|
Subtotal |
|
|
$133,439 |
|
|
|
$80,723 |
|
|
|
$18,131 |
|
|
|
$232,293 |
|
|
|
Investments in funds measured at NAV |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,757 |
|
Total cash instrument assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$240,050 |
|
Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. government and federal agency obligations |
|
|
$ (15,455 |
) |
|
|
$ (61 |
) |
|
|
$ |
|
|
|
$ (15,516 |
) |
|
|
Non-U.S. government and agency obligations |
|
|
(13,522 |
) |
|
|
(1,451 |
) |
|
|
|
|
|
|
(14,973 |
) |
|
|
Loans and securities backed by commercial real estate |
|
|
|
|
|
|
(4 |
) |
|
|
|
|
|
|
(4 |
) |
|
|
Loans and securities backed by residential real estate |
|
|
|
|
|
|
(2 |
) |
|
|
|
|
|
|
(2 |
) |
|
|
Bank loans and bridge loans |
|
|
|
|
|
|
(337 |
) |
|
|
(124 |
) |
|
|
(461 |
) |
|
|
Corporate debt securities |
|
|
(2 |
) |
|
|
(6,119 |
) |
|
|
(2 |
) |
|
|
(6,123 |
) |
|
|
State and municipal obligations |
|
|
|
|
|
|
(2 |
) |
|
|
|
|
|
|
(2 |
) |
|
|
Other debt obligations |
|
|
|
|
|
|
(1 |
) |
|
|
(1 |
) |
|
|
(2 |
) |
|
|
Equities and convertible debentures |
|
|
(30,790 |
) |
|
|
(538 |
) |
|
|
(66 |
) |
|
|
(31,394 |
) |
Total cash instrument liabilities |
|
|
$ (59,769 |
) |
|
|
$ (8,515 |
) |
|
|
$ (193 |
) |
|
|
$ (68,477 |
) |
In the tables above:
|
|
Total cash instrument assets includes collateralized debt obligations (CDOs) and collateralized loan
obligations (CLOs) backed by real estate and corporate obligations of $419 million in level 2 and $793 million in level 3 as of March 2016, and $405 million in level 2 and $774 million in level 3 as of
December 2015, respectively. |
|
|
Level 3 equities and convertible debentures includes $7.76 billion of private equity investments,
$303 million of investments in real estate entities and $414 million of convertible debentures as of March 2016, and $7.69 billion of private equity investments, $308 million of investments in real estate entities and
$552 million of convertible debentures as of December 2015. |
|
|
|
|
|
18 |
|
Goldman Sachs March 2016 Form 10-Q |
|
|
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Significant Unobservable Inputs
The table below presents the amount of level 3 assets, and ranges and weighted averages of significant unobservable inputs used to value the
firms level 3 cash instruments.
|
|
|
|
|
|
|
Level 3 Assets and Range of Significant
Unobservable Inputs (Weighted Average) as of |
$ in millions |
|
March 2016 |
|
December 2015 |
Loans and securities backed by commercial real estate |
|
$2,168 |
|
$1,924 |
|
Yield |
|
2.2% to 24.0% (12.7%) |
|
3.5% to 22.0% (11.8%) |
|
Recovery rate |
|
18.9% to 98.9% (59.7%) |
|
19.6% to 96.5% (59.4%) |
|
Duration (years) |
|
0.3 to 5.0 (2.0) |
|
0.3 to 5.3 (2.3) |
|
Basis (points) |
|
(12) to 6 ((2)) |
|
(11) to 4 ((2)) |
Loans and securities backed by residential real estate |
|
$1,434 |
|
$1,765 |
|
Yield |
|
3.0% to 13.3% (8.3%) |
|
3.2% to 17.0% (7.9%) |
|
Cumulative loss rate |
|
3.2% to 35.2% (26.3%) |
|
4.6% to 44.2% (27.3%) |
|
Duration (years) |
|
1.4 to 14.1 (6.8) |
|
1.5 to 13.8 (7.0) |
Bank loans and bridge loans |
|
$3,189 |
|
$3,150 |
|
Yield |
|
1.7% to 25.0% (9.6%) |
|
1.9% to 36.6% (10.2%) |
|
Recovery rate |
|
5.9% to 85.2% (49.2%) |
|
14.5% to 85.6% (51.2%) |
|
Duration (years) |
|
0.6 to 5.7 (2.7) |
|
0.7 to 6.1 (2.2) |
Equities and convertible debentures |
|
$8,474 |
|
$8,549 |
|
Multiples |
|
0.7x to 17.8x (6.3x) |
|
0.7x to 21.4x (6.4x) |
|
Discount rate/yield |
|
6.5% to 30.0% (15.1%) |
|
7.1% to 20.0% (14.8%) |
|
Long-term growth rate/compound annual growth rate |
|
3.0% to 5.2% (4.5%) |
|
3.0% to 5.2% (4.5%) |
|
Capitalization rate |
|
5.0% to 12.0% (7.1%) |
|
5.5% to 12.5% (7.6%) |
Other cash instruments |
|
$3,204 |
|
$2,743 |
|
Yield |
|
1.5% to 18.4% (11.5%) |
|
0.9% to 25.6% (10.9%) |
|
Recovery rate |
|
0.0% to 90.9% (62.3%) |
|
0.0% to 70.0% (59.7%) |
|
Duration (years) |
|
1.2 to 16.5 (4.0) |
|
1.1 to 11.4 (4.5) |
In the table above:
|
|
Ranges represent the significant unobservable inputs that were used in the valuation of each type of cash
instrument. |
|
|
Weighted averages are calculated by weighting each input by the relative fair value of the cash instruments.
|
|
|
The ranges and weighted averages of these inputs are not representative of the appropriate inputs to use when
calculating the fair value of any one cash instrument. For example, the highest multiple for private equity investments is appropriate for valuing a specific private equity investment but may not be appropriate for valuing any other private equity
investment. Accordingly, the ranges of inputs do not represent uncertainty in, or possible ranges of, fair value measurements of the firms level 3 cash instruments.
|
|
|
Increases in yield, discount rate, capitalization rate, duration or cumulative loss rate used in the valuation
of the firms level 3 cash instruments would result in a lower fair value measurement, while increases in recovery rate, basis, multiples, long-term growth rate or compound annual growth rate would result in a higher fair value
measurement. Due to the distinctive nature of each of the firms level 3 cash instruments, the interrelationship of inputs is not necessarily uniform within each product type. |
|
|
Equities and convertible debentures include private equity investments and investments in real estate
entities. |
|
|
Loans and securities backed by commercial and residential real estate, bank loans and bridge loans and other
cash instruments are valued using discounted cash flows, and equities and convertible debentures are valued using market comparables and discounted cash flows. |
|
|
The fair value of any one instrument may be determined using multiple valuation techniques. For example,
market comparables and discounted cash flows may be used together to determine fair value. Therefore, the level 3 balance encompasses both of these techniques. |
Transfers Between Levels of the Fair Value Hierarchy
Transfers between levels of the fair value hierarchy are reported at the beginning of the reporting period in which they occur.
During the three months ended March 2016:
|
|
Transfers into level 2 from level 1 of cash instruments were $137 million, reflecting transfers
of public equity securities primarily due to decreased market activity in these instruments. |
|
|
Transfers into level 1 from level 2 of cash instruments were $195 million, primarily reflecting
transfers of public equity securities principally due to increased market activity in these instruments. |
During the
three months ended March 2015:
|
|
Transfers into level 2 from level 1 of cash instruments were $141 million, reflecting transfers
of public equity securities primarily due to decreased market activity in these instruments. |
|
|
Transfers into level 1 from level 2 of cash instruments were $237 million, reflecting transfers
of public equity securities due to increased market activity in these instruments. |
See level 3 rollforward below
for information about transfers between level 2 and level 3.
|
|
|
|
|
|
|
Goldman Sachs March 2016 Form 10-Q |
|
19 |
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Level 3 Rollforward
The table below presents changes in fair value for all cash instrument assets and liabilities
categorized as level 3 as of the end of the period. In the table below:
|
|
If a cash instrument asset or liability was transferred to level 3 during a reporting period, its entire
gain or loss for the period is included in level 3. For level 3 cash instrument assets, increases are shown as positive amounts, while decreases are shown as negative amounts. For level 3 cash instrument liabilities, increases are
shown as negative amounts, while decreases are shown as positive amounts. |
|
|
Level 3 cash instruments are frequently economically hedged with level 1 and level 2 cash
instruments and/or level 1, level 2 or level 3 derivatives. Accordingly, gains or losses that are reported in level 3 can be partially offset by gains or losses attributable to level 1 or level 2 cash instruments and/or
level 1, level 2 or level 3 derivatives. As a result, gains or losses included in the level 3 rollforward below do not necessarily represent the overall impact on the firms results of operations, liquidity or capital
resources. |
|
|
Purchases include both originations and secondary market purchases.
|
|
|
Net unrealized gains/(losses) relate to instruments that were still held at period-end. |
|
|
For the three months ended March 2016, the net realized and unrealized gains on level 3 cash
instrument assets of $110 million (reflecting $150 million of realized gains and $40 million of unrealized losses) include gains/(losses) of approximately $(115) million, $9 million and $216 million reported in
Market making, Other principal transactions and Interest income, respectively. |
|
|
For the three months ended March 2015, the net realized and unrealized gains on level 3 cash
instrument assets of $676 million (reflecting $273 million of realized gains and $403 million of unrealized gains) include gains of approximately $94 million, $376 million and $206 million reported in Market
making, Other principal transactions and Interest income, respectively. |
|
|
See Level 3 Rollforward Commentary below for an explanation of the net unrealized
gains/(losses) on level 3 cash instruments and the activity related to transfers into and out of level 3.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Level 3 Cash Instrument Assets and Liabilities at Fair Value |
|
$ in millions |
|
|
Balance, beginning of period |
|
|
|
Net realized gains/ (losses) |
|
|
|
Net unrealized gains/ (losses) |
|
|
|
Purchases |
|
|
|
Sales |
|
|
|
Settlements |
|
|
|
Transfers into level 3 |
|
|
|
Transfers out of level 3 |
|
|
|
Balance, end of period |
|
Three Months Ended March 2016 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-U.S. government and agency obligations |
|
|
$ 12 |
|
|
|
$ 1 |
|
|
|
$ |
|
|
|
$ 20 |
|
|
|
$ (11 |
) |
|
|
$ |
|
|
|
$ 36 |
|
|
|
$ |
|
|
|
$ 58 |
|
|
|
Loans and securities backed by commercial real estate |
|
|
1,924 |
|
|
|
21 |
|
|
|
(8 |
) |
|
|
340 |
|
|
|
(135 |
) |
|
|
(123 |
) |
|
|
253 |
|
|
|
(104 |
) |
|
|
2,168 |
|
|
|
Loans and securities backed by residential real estate |
|
|
1,765 |
|
|
|
12 |
|
|
|
45 |
|
|
|
61 |
|
|
|
(298 |
) |
|
|
(82 |
) |
|
|
132 |
|
|
|
(201 |
) |
|
|
1,434 |
|
|
|
Bank loans and bridge loans |
|
|
3,150 |
|
|
|
33 |
|
|
|
6 |
|
|
|
183 |
|
|
|
(67 |
) |
|
|
(425 |
) |
|
|
511 |
|
|
|
(202 |
) |
|
|
3,189 |
|
|
|
Corporate debt securities |
|
|
2,092 |
|
|
|
41 |
|
|
|
2 |
|
|
|
404 |
|
|
|
(70 |
) |
|
|
(67 |
) |
|
|
291 |
|
|
|
(91 |
) |
|
|
2,602 |
|
|
|
State and municipal obligations |
|
|
101 |
|
|
|
1 |
|
|
|
|
|
|
|
6 |
|
|
|
(31 |
) |
|
|
(1 |
) |
|
|
22 |
|
|
|
(12 |
) |
|
|
86 |
|
|
|
Other debt obligations |
|
|
538 |
|
|
|
9 |
|
|
|
(3 |
) |
|
|
24 |
|
|
|
(86 |
) |
|
|
(38 |
) |
|
|
28 |
|
|
|
(14 |
) |
|
|
458 |
|
|
|
Equities and convertible debentures |
|
|
8,549 |
|
|
|
32 |
|
|
|
(82 |
) |
|
|
380 |
|
|
|
(96 |
) |
|
|
(250 |
) |
|
|
295 |
|
|
|
(354 |
) |
|
|
8,474 |
|
Total cash instrument assets |
|
|
$18,131 |
|
|
|
$150 |
|
|
|
$ (40 |
) |
|
|
$1,418 |
|
|
|
$ (794 |
) |
|
|
$ (986 |
) |
|
|
$1,568 |
|
|
|
$ (978 |
) |
|
|
$18,469 |
|
Total cash instrument liabilities |
|
|
$ (193 |
) |
|
|
$ 3 |
|
|
|
$ 8 |
|
|
|
$ 58 |
|
|
|
$ (26 |
) |
|
|
$ (1 |
) |
|
|
$ (18 |
) |
|
|
$ 31 |
|
|
|
$ (138 |
) |
Three Months Ended
March 2015 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial paper, certificates of deposit, time deposits and other money market instruments |
|
|
$ |
|
|
|
$ |
|
|
|
$ (1 |
) |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ 11 |
|
|
|
$ |
|
|
|
$ 10 |
|
|
|
Non-U.S. government and agency obligations |
|
|
136 |
|
|
|
1 |
|
|
|
|
|
|
|
1 |
|
|
|
(24 |
) |
|
|
(19 |
) |
|
|
|
|
|
|
|
|
|
|
95 |
|
|
|
Loans and securities backed by commercial real estate |
|
|
3,275 |
|
|
|
35 |
|
|
|
(23 |
) |
|
|
101 |
|
|
|
(149 |
) |
|
|
(855 |
) |
|
|
414 |
|
|
|
(35 |
) |
|
|
2,763 |
|
|
|
Loans and securities backed by residential real estate |
|
|
2,545 |
|
|
|
48 |
|
|
|
62 |
|
|
|
386 |
|
|
|
(268 |
) |
|
|
(183 |
) |
|
|
280 |
|
|
|
(97 |
) |
|
|
2,773 |
|
|
|
Bank loans and bridge loans |
|
|
6,973 |
|
|
|
96 |
|
|
|
(108 |
) |
|
|
405 |
|
|
|
(400 |
) |
|
|
(928 |
) |
|
|
719 |
|
|
|
(446 |
) |
|
|
6,311 |
|
|
|
Corporate debt securities |
|
|
3,633 |
|
|
|
38 |
|
|
|
(12 |
) |
|
|
169 |
|
|
|
(367 |
) |
|
|
(216 |
) |
|
|
369 |
|
|
|
(848 |
) |
|
|
2,766 |
|
|
|
State and municipal obligations |
|
|
110 |
|
|
|
|
|
|
|
1 |
|
|
|
27 |
|
|
|
(3 |
) |
|
|
1 |
|
|
|
33 |
|
|
|
(27 |
) |
|
|
142 |
|
|
|
Other debt obligations |
|
|
870 |
|
|
|
16 |
|
|
|
7 |
|
|
|
150 |
|
|
|
(41 |
) |
|
|
(55 |
) |
|
|
16 |
|
|
|
(77 |
) |
|
|
886 |
|
|
|
Equities and convertible debentures |
|
|
11,108 |
|
|
|
39 |
|
|
|
477 |
|
|
|
168 |
|
|
|
(114 |
) |
|
|
(446 |
) |
|
|
442 |
|
|
|
(185 |
) |
|
|
11,489 |
|
Total cash instrument assets |
|
|
$28,650 |
|
|
|
$273 |
|
|
|
$ 403 |
|
|
|
$1,407 |
|
|
|
$(1,366 |
) |
|
|
$(2,701 |
) |
|
|
$2,284 |
|
|
|
$(1,715 |
) |
|
|
$27,235 |
|
Total cash instrument liabilities |
|
|
$ (244 |
) |
|
|
$ (3 |
) |
|
|
$ 28 |
|
|
|
$ 56 |
|
|
|
$ (24 |
) |
|
|
$ |
|
|
|
$ (41 |
) |
|
|
$ 66 |
|
|
|
$ (162 |
) |
|
|
|
|
|
20 |
|
Goldman Sachs March 2016 Form 10-Q |
|
|
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Level 3 Rollforward Commentary
Three Months Ended March 2016. The net unrealized
loss on level 3 cash instruments of $32 million (reflecting a $40 million loss on cash instrument assets and a $8 million gain on cash instrument liabilities) for the three months ended March 2016 reflected losses on private
equity investments principally driven by lower global equity prices and corporate performance.
Transfers into level 3 during
the three months ended March 2016 primarily reflected transfers of certain bank loans and bridge loans, private equity investments, corporate debt securities and loans and securities backed by commercial real estate from level 2, principally
due to reduced price transparency as a result of a lack of market evidence, including fewer market transactions in these instruments, and transfers of certain other corporate debt securities from level 2 principally due to certain unobservable
yield inputs becoming significant to the valuation of these instruments.
Transfers out of level 3 during the three months ended
March 2016 primarily reflected transfers of certain private equity investments, bank loans and bridge loans and loans and securities backed by residential real estate to level 2, principally due to increased price transparency as a result
of market evidence, including market transactions in these instruments.
Three Months Ended
March 2015. The net unrealized gain on level 3 cash instruments of $431 million (reflecting a $403 million gain on cash instrument assets and a $28 million gain on cash
instrument liabilities) for the three months ended March 2015 primarily reflected gains on private equity investments principally driven by strong corporate performance and company-specific events.
Transfers into level 3 during the three months ended March 2015 primarily reflected transfers of certain bank loans and bridge loans,
private equity investments and loans and securities backed by commercial real estate from level 2 principally due to reduced price transparency as a result of a lack of market evidence, including fewer market transactions in these instruments.
Transfers out of level 3 during the three months ended March 2015 primarily reflected transfers of certain corporate debt
securities, bank loans and bridge loans and private equity investments to level 2 principally due to increased price transparency as a result of market evidence, including additional market transactions in these instruments.
Investments in Funds That Are Measured at Net Asset Value Per Share
Cash instruments at fair value include investments in funds that are measured at NAV of the investment fund. The firm uses NAV to measure the
fair value of its fund investments when (i) the fund investment does not have a readily determinable fair value and (ii) the NAV of the investment fund is calculated in a manner consistent with the measurement principles of investment
company accounting, including measurement of the investments at fair value.
The firms investments in funds measured at NAV primarily
consist of investments in firm-sponsored private equity, credit, real estate and hedge funds where the firm co-invests with third-party investors.
Private equity funds primarily invest in a broad range of industries worldwide, including leveraged buyouts, recapitalizations, growth
investments and distressed investments. Credit funds generally invest in loans and other fixed income instruments and are focused on providing private high-yield capital for leveraged and management buyout transactions, recapitalizations,
financings, refinancings, acquisitions and restructurings for private equity firms, private family companies and corporate issuers. Real estate funds invest globally, primarily in real estate companies, loan portfolios, debt recapitalizations and
property. The private equity, credit and real estate funds are primarily closed-end funds in which the firms investments are generally not eligible for redemption. Distributions will be received from these funds as the underlying assets are
liquidated or distributed.
The firm also invests in hedge funds, primarily multi-disciplinary hedge funds that employ a fundamental
bottom-up investment approach across various asset classes and strategies. The firms investments in hedge funds primarily include interests where the underlying assets are illiquid in nature, and proceeds from redemptions will not be received
until the underlying assets are liquidated or distributed.
Many of the funds described above are covered funds as defined by
the Volcker Rule of the U.S. Dodd-Frank Wall Street Reform and Consumer Protection Act (Dodd-Frank Act). The Board of Governors of the Federal Reserve System (Federal Reserve Board) extended the conformance period through July 2016 for
investments in, and relationships with, covered funds that were in place prior to December 2013, and indicated that it intends to further extend the conformance period through July 2017.
|
|
|
|
|
|
|
Goldman Sachs March 2016 Form 10-Q |
|
21 |
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
The firm currently expects to be able to exit the majority of such interests in these funds in
orderly transactions prior to July 2017, subject to market conditions. However, to the extent that the underlying investments of particular funds are not sold, the firm may be required to sell its interests in such funds. If that occurs, the
firm may receive a value for its interests that is less than the then carrying value as there could be a limited secondary market for these investments and the firm may be unable to sell them in orderly transactions. In order to be compliant with
the Volcker Rule, the firm will be required to reduce most of its interests in the funds in the table below by the end of the conformance period.
The table below presents the fair value of the firms investments in, and unfunded commitments to, funds that are measured at NAV.
|
|
|
|
|
|
|
|
|
$ in millions |
|
|
Fair Value of Investments |
|
|
|
Unfunded Commitments |
|
As of March 2016 |
|
|
|
|
|
|
|
|
Private equity funds |
|
|
$4,961 |
|
|
|
$2,020 |
|
|
|
Credit funds |
|
|
498 |
|
|
|
319 |
|
|
|
Hedge funds |
|
|
548 |
|
|
|
|
|
|
|
Real estate funds |
|
|
1,170 |
|
|
|
215 |
|
Total |
|
|
$7,177 |
|
|
|
$2,554 |
|
As of December 2015 |
|
|
|
|
|
|
|
|
Private equity funds |
|
|
$5,414 |
|
|
|
$2,057 |
|
|
|
Credit funds |
|
|
611 |
|
|
|
344 |
|
|
|
Hedge funds |
|
|
560 |
|
|
|
|
|
|
|
Real estate funds |
|
|
1,172 |
|
|
|
296 |
|
Total |
|
|
$7,757 |
|
|
|
$2,697 |
|
Note 7.
Derivatives and Hedging Activities
Derivative Activities
Derivatives are instruments that derive their value from underlying asset prices, indices, reference rates and other inputs, or a combination
of these factors. Derivatives may be traded on an exchange (exchange-traded) or they may be privately negotiated contracts, which are usually referred to as OTC derivatives. Certain of the firms OTC derivatives are cleared and settled through
central clearing counterparties (OTC-cleared), while others are bilateral contracts between two counterparties (bilateral OTC).
Market-Making. As a market maker, the firm enters into derivative transactions to provide liquidity to clients and to facilitate the transfer and hedging of their
risks. In this capacity, the firm typically acts as principal and is required to commit capital to provide execution. As a market maker, it is essential to maintain an inventory of financial instruments sufficient to meet expected client and market
demands.
Risk Management. The firm also enters into derivatives to actively manage risk exposures that arise from its market-making and investing and lending activities in derivative and cash instruments. The firms holdings and
exposures are hedged, in many cases, on either a portfolio or risk-specific basis, as opposed to an instrument-by-instrument basis. The offsetting impact of this economic hedging is reflected in the same business segment as the related revenues. In
addition, the firm may enter into derivatives designated as hedges under U.S. GAAP. These derivatives are used to manage interest rate exposure in certain fixed-rate unsecured long-term and short-term borrowings, and deposits, and to manage foreign
currency exposure on the net investment in certain non-U.S. operations.
The firm enters into various types of derivatives,
including:
|
|
Futures and Forwards. Contracts that commit counterparties to
purchase or sell financial instruments, commodities or currencies in the future. |
|
|
Swaps. Contracts that require counterparties to exchange cash
flows such as currency or interest payment streams. The amounts exchanged are based on the specific terms of the contract with reference to specified rates, financial instruments, commodities, currencies or indices. |
|
|
Options. Contracts in which the option purchaser has the right,
but not the obligation, to purchase from or sell to the option writer financial instruments, commodities or currencies within a defined time period for a specified price. |
Derivatives are reported on a net-by-counterparty basis (i.e., the net payable or receivable for derivative assets and liabilities for a given
counterparty) when a legal right of setoff exists under an enforceable netting agreement (counterparty netting). Derivatives are accounted for at fair value, net of cash collateral received or posted under enforceable credit support agreements (cash
collateral netting). Derivative assets and liabilities are included in Financial instruments owned, at fair value and Financial instruments sold, but not yet purchased, at fair value, respectively. Realized and unrealized
gains and losses on derivatives not designated as hedges under ASC 815 are included in Market making and Other principal transactions in Note 4.
|
|
|
|
|
22 |
|
Goldman Sachs March 2016 Form 10-Q |
|
|
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
The table below presents the gross fair value and the notional amount of derivative contracts by
major product type, the amounts of counterparty and cash collateral netting in the condensed consolidated statements of financial condition, as well as cash and securities collateral posted and received under enforceable credit support agreements
that do not meet the criteria for netting under U.S. GAAP.
In the table below:
|
|
Gross fair values exclude the effects of both counterparty netting and collateral, and therefore are not
representative of the firms exposure. |
|
|
Where the firm has received or posted collateral under credit support agreements, but has not yet determined
such agreements are enforceable, the related collateral has not been netted. |
|
|
Notional amounts, which represent the sum of gross long and short derivative contracts, provide an indication
of the volume of the firms derivative activity and do not represent anticipated losses. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of March 2016 |
|
|
|
|
As of December 2015 |
|
$ in millions |
|
|
Derivative Assets |
|
|
|
Derivative Liabilities |
|
|
|
Notional Amount |
|
|
|
|
|
Derivative Assets |
|
|
|
Derivative Liabilities |
|
|
|
Notional Amount |
|
Derivatives not accounted for as hedges |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exchange-traded |
|
|
$ 393 |
|
|
|
$ 464 |
|
|
|
$ 5,746,768 |
|
|
|
|
|
$ 310 |
|
|
|
$ 280 |
|
|
|
$ 4,402,843 |
|
|
|
OTC-cleared |
|
|
322,805 |
|
|
|
306,746 |
|
|
|
23,524,475 |
|
|
|
|
|
211,272 |
|
|
|
192,401 |
|
|
|
20,738,687 |
|
|
|
Bilateral OTC |
|
|
435,907 |
|
|
|
409,229 |
|
|
|
13,039,635 |
|
|
|
|
|
345,516 |
|
|
|
321,458 |
|
|
|
12,953,830 |
|
Total interest rates |
|
|
759,105 |
|
|
|
716,439 |
|
|
|
42,310,878 |
|
|
|
|
|
557,098 |
|
|
|
514,139 |
|
|
|
38,095,360 |
|
OTC-cleared |
|
|
5,695 |
|
|
|
6,006 |
|
|
|
443,266 |
|
|
|
|
|
5,203 |
|
|
|
5,596 |
|
|
|
339,244 |
|
|
|
Bilateral OTC |
|
|
33,142 |
|
|
|
28,635 |
|
|
|
1,536,544 |
|
|
|
|
|
35,679 |
|
|
|
31,179 |
|
|
|
1,552,806 |
|
Total credit |
|
|
38,837 |
|
|
|
34,641 |
|
|
|
1,979,810 |
|
|
|
|
|
40,882 |
|
|
|
36,775 |
|
|
|
1,892,050 |
|
Exchange-traded |
|
|
51 |
|
|
|
108 |
|
|
|
21,293 |
|
|
|
|
|
183 |
|
|
|
204 |
|
|
|
13,073 |
|
|
|
OTC-cleared |
|
|
267 |
|
|
|
242 |
|
|
|
19,281 |
|
|
|
|
|
165 |
|
|
|
128 |
|
|
|
14,617 |
|
|
|
Bilateral OTC |
|
|
108,252 |
|
|
|
113,147 |
|
|
|
6,050,000 |
|
|
|
|
|
96,660 |
|
|
|
99,235 |
|
|
|
5,461,940 |
|
Total currencies |
|
|
108,570 |
|
|
|
113,497 |
|
|
|
6,090,574 |
|
|
|
|
|
97,008 |
|
|
|
99,567 |
|
|
|
5,489,630 |
|
Exchange-traded |
|
|
5,128 |
|
|
|
5,379 |
|
|
|
268,221 |
|
|
|
|
|
2,997 |
|
|
|
3,623 |
|
|
|
203,465 |
|
|
|
OTC-cleared |
|
|
167 |
|
|
|
236 |
|
|
|
2,742 |
|
|
|
|
|
232 |
|
|
|
233 |
|
|
|
2,839 |
|
|
|
Bilateral OTC |
|
|
14,575 |
|
|
|
15,344 |
|
|
|
235,205 |
|
|
|
|
|
17,445 |
|
|
|
17,215 |
|
|
|
230,750 |
|
Total commodities |
|
|
19,870 |
|
|
|
20,959 |
|
|
|
506,168 |
|
|
|
|
|
20,674 |
|
|
|
21,071 |
|
|
|
437,054 |
|
Exchange-traded |
|
|
9,545 |
|
|
|
8,343 |
|
|
|
538,880 |
|
|
|
|
|
9,372 |
|
|
|
7,908 |
|
|
|
528,419 |
|
|
|
Bilateral OTC |
|
|
39,939 |
|
|
|
41,986 |
|
|
|
952,522 |
|
|
|
|
|
37,788 |
|
|
|
38,290 |
|
|
|
927,078 |
|
Total equities |
|
|
49,484 |
|
|
|
50,329 |
|
|
|
1,491,402 |
|
|
|
|
|
47,160 |
|
|
|
46,198 |
|
|
|
1,455,497 |
|
Subtotal |
|
|
975,866 |
|
|
|
935,865 |
|
|
|
52,378,832 |
|
|
|
|
|
762,822 |
|
|
|
717,750 |
|
|
|
47,369,591 |
|
Derivatives accounted for as hedges |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OTC-cleared |
|
|
6,606 |
|
|
|
84 |
|
|
|
58,840 |
|
|
|
|
|
4,567 |
|
|
|
85 |
|
|
|
51,446 |
|
|
|
Bilateral OTC |
|
|
6,373 |
|
|
|
22 |
|
|
|
54,940 |
|
|
|
|
|
6,660 |
|
|
|
20 |
|
|
|
62,022 |
|
Total interest rates |
|
|
12,979 |
|
|
|
106 |
|
|
|
113,780 |
|
|
|
|
|
11,227 |
|
|
|
105 |
|
|
|
113,468 |
|
OTC-cleared |
|
|
6 |
|
|
|
29 |
|
|
|
1,364 |
|
|
|
|
|
24 |
|
|
|
6 |
|
|
|
1,333 |
|
|
|
Bilateral OTC |
|
|
25 |
|
|
|
211 |
|
|
|
9,189 |
|
|
|
|
|
116 |
|
|
|
27 |
|
|
|
8,615 |
|
Total currencies |
|
|
31 |
|
|
|
240 |
|
|
|
10,553 |
|
|
|
|
|
140 |
|
|
|
33 |
|
|
|
9,948 |
|
Subtotal |
|
|
13,010 |
|
|
|
346 |
|
|
|
124,333 |
|
|
|
|
|
11,367 |
|
|
|
138 |
|
|
|
123,416 |
|
Total gross fair value/notional amount of
derivatives |
|
|
$ 988,876 |
1 |
|
|
$ 936,211 |
1 |
|
|
$52,503,165 |
|
|
|
|
|
$ 774,189 |
1 |
|
|
$ 717,888 |
1 |
|
|
$47,493,007 |
|
Amounts that have been offset in the condensed consolidated statements of financial
condition |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exchange-traded |
|
|
$ (11,374 |
) |
|
|
$ (11,374 |
) |
|
|
|
|
|
|
|
|
$ (9,398 |
) |
|
|
$ (9,398 |
) |
|
|
|
|
|
|
OTC-cleared |
|
|
(310,428 |
) |
|
|
(310,428 |
) |
|
|
|
|
|
|
|
|
(194,928 |
) |
|
|
(194,928 |
) |
|
|
|
|
|
|
Bilateral OTC |
|
|
(512,487 |
) |
|
|
(512,487 |
) |
|
|
|
|
|
|
|
|
(426,841 |
) |
|
|
(426,841 |
) |
|
|
|
|
Total counterparty netting |
|
|
(834,289 |
) |
|
|
(834,289 |
) |
|
|
|
|
|
|
|
|
(631,167 |
) |
|
|
(631,167 |
) |
|
|
|
|
OTC-cleared |
|
|
(24,829 |
) |
|
|
(2,599 |
) |
|
|
|
|
|
|
|
|
(26,151 |
) |
|
|
(3,305 |
) |
|
|
|
|
|
|
Bilateral OTC |
|
|
(69,087 |
) |
|
|
(45,140 |
) |
|
|
|
|
|
|
|
|
(62,981 |
) |
|
|
(36,645 |
) |
|
|
|
|
Total cash collateral netting |
|
|
(93,916 |
) |
|
|
(47,739 |
) |
|
|
|
|
|
|
|
|
(89,132 |
) |
|
|
(39,950 |
) |
|
|
|
|
Total counterparty and cash collateral netting |
|
|
$(928,205 |
) |
|
|
$(882,028 |
) |
|
|
|
|
|
|
|
|
$(720,299 |
) |
|
|
$(671,117 |
) |
|
|
|
|
Amounts included in financial instruments owned/financial instruments sold, but not yet
purchased |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exchange-traded |
|
|
$ 3,743 |
|
|
|
$ 2,920 |
|
|
|
|
|
|
|
|
|
$ 3,464 |
|
|
|
$ 2,617 |
|
|
|
|
|
|
|
OTC-cleared |
|
|
289 |
|
|
|
316 |
|
|
|
|
|
|
|
|
|
384 |
|
|
|
216 |
|
|
|
|
|
|
|
Bilateral OTC |
|
|
56,639 |
|
|
|
50,947 |
|
|
|
|
|
|
|
|
|
50,042 |
|
|
|
43,938 |
|
|
|
|
|
Total amounts included in the condensed consolidated
statements of financial condition |
|
|
$ 60,671 |
|
|
|
$ 54,183 |
|
|
|
|
|
|
|
|
|
$ 53,890 |
|
|
|
$ 46,771 |
|
|
|
|
|
Amounts that have not been offset in the condensed consolidated statements of financial
condition |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash collateral received/posted |
|
|
$ (546 |
) |
|
|
$ (2,725 |
) |
|
|
|
|
|
|
|
|
$ (498 |
) |
|
|
$ (1,935 |
) |
|
|
|
|
|
|
Securities collateral received/posted |
|
|
(16,108 |
) |
|
|
(14,430 |
) |
|
|
|
|
|
|
|
|
(14,008 |
) |
|
|
(10,044 |
) |
|
|
|
|
Total |
|
|
$ 44,017 |
|
|
|
$ 37,028 |
|
|
|
|
|
|
|
|
|
$ 39,384 |
|
|
|
$ 34,792 |
|
|
|
|
|
1. |
Includes derivative assets and derivative liabilities of $22.33 billion and $23.50 billion, respectively, as of
March 2016, and derivative assets and derivative liabilities of $17.09 billion and $18.16 billion, respectively, as of December 2015, which are not subject to an enforceable netting agreement or are subject to a netting agreement
that the firm has not yet determined to be enforceable. |
|
|
|
|
|
|
|
Goldman Sachs March 2016 Form 10-Q |
|
23 |
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Valuation Techniques for Derivatives
The firms level 2 and level 3 derivatives are valued using derivative pricing models (e.g., discounted cash flow models,
correlation models, and models that incorporate option pricing methodologies, such as Monte Carlo simulations). Price transparency of derivatives can generally be characterized by product type, as described below.
|
|
Interest Rate. In general, the key inputs used to value interest
rate derivatives are transparent, even for most long-dated contracts. Interest rate swaps and options denominated in the currencies of leading industrialized nations are characterized by high trading volumes and tight bid/offer spreads. Interest
rate derivatives that reference indices, such as an inflation index, or the shape of the yield curve (e.g., 10-year swap rate vs. 2-year swap rate) are more complex, but the key inputs are generally observable. |
|
|
Credit. Price transparency for credit default swaps, including
both single names and baskets of credits, varies by market and underlying reference entity or obligation. Credit default swaps that reference indices, large corporates and major sovereigns generally exhibit the most price transparency. For credit
default swaps with other underliers, price transparency varies based on credit rating, the cost of borrowing the underlying reference obligations, and the availability of the underlying reference obligations for delivery upon the default of the
issuer. Credit default swaps that reference loans, asset-backed securities and emerging market debt instruments tend to have less price transparency than those that reference corporate bonds. In addition, more complex credit derivatives, such as
those sensitive to the correlation between two or more underlying reference obligations, generally have less price transparency. |
|
|
Currency. Prices for currency derivatives based on the exchange
rates of leading industrialized nations, including those with longer tenors, are generally transparent. The primary difference between the price transparency of developed and emerging market currency derivatives is that emerging markets tend to be
observable for contracts with shorter tenors.
|
|
|
Commodity. Commodity derivatives include transactions referenced
to energy (e.g., oil and natural gas), metals (e.g., precious and base) and soft commodities (e.g., agricultural). Price transparency varies based on the underlying commodity, delivery location, tenor and product quality (e.g., diesel fuel compared
to unleaded gasoline). In general, price transparency for commodity derivatives is greater for contracts with shorter tenors and contracts that are more closely aligned with major and/or benchmark commodity indices. |
|
|
Equity. Price transparency for equity derivatives varies by
market and underlier. Options on indices and the common stock of corporates included in major equity indices exhibit the most price transparency. Equity derivatives generally have observable market prices, except for contracts with long tenors or
reference prices that differ significantly from current market prices. More complex equity derivatives, such as those sensitive to the correlation between two or more individual stocks, generally have less price transparency. |
Liquidity is essential to observability of all product types. If transaction volumes decline, previously transparent prices and other inputs
may become unobservable. Conversely, even highly structured products may at times have trading volumes large enough to provide observability of prices and other inputs. See Note 5 for an overview of the firms fair value measurement
policies.
Level 1 Derivatives
Level 1 derivatives include short-term contracts for future delivery of securities when the underlying security is a level 1
instrument, and exchange-traded derivatives if they are actively traded and are valued at their quoted market price.
Level 2 Derivatives
Level 2 derivatives include OTC derivatives for which all significant valuation inputs are corroborated by market evidence and
exchange-traded derivatives that are not actively traded and/or that are valued using models that calibrate to market-clearing levels of OTC derivatives. In evaluating the significance of a valuation input, the firm considers, among other factors, a
portfolios net risk exposure to that input.
|
|
|
|
|
24 |
|
Goldman Sachs March 2016 Form 10-Q |
|
|
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
The selection of a particular model to value a derivative depends on the contractual terms of
and specific risks inherent in the instrument, as well as the availability of pricing information in the market. For derivatives that trade in liquid markets, model selection does not involve significant management judgment because outputs of models
can be calibrated to market-clearing levels.
Valuation models require a variety of inputs, such as contractual terms, market prices, yield
curves, discount rates (including those derived from interest rates on collateral received and posted as specified in credit support agreements for collateralized derivatives), credit curves, measures of volatility, prepayment rates, loss severity
rates and correlations of such inputs. Significant inputs to the valuations of level 2 derivatives can be verified to market transactions, broker or dealer quotations or other alternative pricing sources with reasonable levels of price
transparency. Consideration is given to the nature of the quotations (e.g., indicative or firm) and the relationship of recent market activity to the prices provided from alternative pricing sources.
Level 3 Derivatives
Level 3 derivatives
are valued using models which utilize observable level 1 and/or level 2 inputs, as well as unobservable level 3 inputs. The significant unobservable inputs used to value the firms level 3 derivatives are described below.
|
|
For the majority of the firms interest rate and currency derivatives classified within level 3,
significant unobservable inputs include correlations of certain currencies and interest rates (e.g., the correlation between Euro inflation and Euro interest rates) and specific interest rate volatilities. |
|
|
For level 3 credit derivatives, significant unobservable inputs include illiquid credit spreads and
upfront credit points, which are unique to specific reference obligations and reference entities, recovery rates and certain correlations required to value credit and mortgage derivatives (e.g., the likelihood of default of the underlying reference
obligation relative to one another).
|
|
|
For level 3 commodity derivatives, significant unobservable inputs include volatilities for options with
strike prices that differ significantly from current market prices and prices or spreads for certain products for which the product quality or physical location of the commodity is not aligned with benchmark indices. |
|
|
For level 3 equity derivatives, significant unobservable inputs generally include equity volatility
inputs for options that are long-dated and/or have strike prices that differ significantly from current market prices. In addition, the valuation of certain structured trades requires the use of level 3 correlation inputs, such as the
correlation of the price performance of two or more individual stocks or the correlation of the price performance for a basket of stocks to another asset class such as commodities. |
Subsequent to the initial valuation of a level 3 derivative, the firm updates the level 1 and level 2 inputs to reflect
observable market changes and any resulting gains and losses are recorded in level 3. Level 3 inputs are changed when corroborated by evidence such as similar market transactions, third-party pricing services and/or broker or dealer
quotations or other empirical market data. In circumstances where the firm cannot verify the model value by reference to market transactions, it is possible that a different valuation model could produce a materially different estimate of fair
value. See below for further information about significant unobservable inputs used in the valuation of level 3 derivatives.
Valuation Adjustments
Valuation adjustments are integral to determining the fair value of derivative portfolios and are used to adjust the mid-market valuations
produced by derivative pricing models to the appropriate exit price valuation. These adjustments incorporate bid/offer spreads, the cost of liquidity, credit valuation adjustments and funding valuation adjustments, which account for the credit and
funding risk inherent in the uncollateralized portion of derivative portfolios. The firm also makes funding valuation adjustments to collateralized derivatives where the terms of the agreement do not permit the firm to deliver or repledge collateral
received. Market-based inputs are generally used when calibrating valuation adjustments to market-clearing levels.
In addition, for
derivatives that include significant unobservable inputs, the firm makes model or exit price adjustments to account for the valuation uncertainty present in the transaction.
|
|
|
|
|
|
|
Goldman Sachs March 2016 Form 10-Q |
|
25 |
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Fair Value of Derivatives by Level
The tables below present the fair value of derivatives on a gross basis by level and major
product type as well as the impact of netting.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of March 2016 |
|
$ in millions |
|
|
Level 1 |
|
|
|
Level 2 |
|
|
|
Level 3 |
|
|
|
Total |
|
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rates |
|
|
$ 17 |
|
|
|
$ 771,432 |
|
|
|
$ 635 |
|
|
|
$ 772,084 |
|
|
|
Credit |
|
|
|
|
|
|
32,905 |
|
|
|
5,932 |
|
|
|
38,837 |
|
|
|
Currencies |
|
|
|
|
|
|
108,415 |
|
|
|
186 |
|
|
|
108,601 |
|
|
|
Commodities |
|
|
|
|
|
|
19,304 |
|
|
|
566 |
|
|
|
19,870 |
|
|
|
Equities |
|
|
210 |
|
|
|
48,679 |
|
|
|
595 |
|
|
|
49,484 |
|
Gross fair value of derivative assets |
|
|
227 |
|
|
|
980,735 |
|
|
|
7,914 |
|
|
|
988,876 |
|
|
|
Counterparty netting within levels |
|
|
|
|
|
|
(830,841 |
) |
|
|
(1,964 |
) |
|
|
(832,805 |
) |
Subtotal |
|
|
$227 |
|
|
|
$ 149,894 |
|
|
|
$ 5,950 |
|
|
|
$ 156,071 |
|
|
|
Cross-level counterparty netting |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,484 |
) |
|
|
Cash collateral netting |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(93,916 |
) |
Fair value included in financial instruments
owned |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 60,671 |
|
Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rates |
|
|
$ (17 |
) |
|
|
$(715,510 |
) |
|
|
$(1,018 |
) |
|
|
$(716,545 |
) |
|
|
Credit |
|
|
|
|
|
|
(31,530 |
) |
|
|
(3,111 |
) |
|
|
(34,641 |
) |
|
|
Currencies |
|
|
|
|
|
|
(113,560 |
) |
|
|
(177 |
) |
|
|
(113,737 |
) |
|
|
Commodities |
|
|
|
|
|
|
(20,102 |
) |
|
|
(857 |
) |
|
|
(20,959 |
) |
|
|
Equities |
|
|
(8 |
) |
|
|
(47,625 |
) |
|
|
(2,696 |
) |
|
|
(50,329 |
) |
Gross fair value of derivative liabilities |
|
|
(25 |
) |
|
|
(928,327 |
) |
|
|
(7,859 |
) |
|
|
(936,211 |
) |
|
|
Counterparty netting within levels |
|
|
|
|
|
|
830,841 |
|
|
|
1,964 |
|
|
|
832,805 |
|
Subtotal |
|
|
$ (25 |
) |
|
|
$ (97,486 |
) |
|
|
$(5,895 |
) |
|
|
$(103,406 |
) |
|
|
Cross-level counterparty netting |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,484 |
|
|
|
Cash collateral netting |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
47,739 |
|
Fair value included in financial instruments sold,
but not yet purchased |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ (54,183 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 2015 |
|
$ in millions |
|
|
Level 1 |
|
|
|
Level 2 |
|
|
|
Level 3 |
|
|
|
Total |
|
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rates |
|
|
$ 4 |
|
|
|
$ 567,761 |
|
|
|
$ 560 |
|
|
|
$ 568,325 |
|
|
|
Credit |
|
|
|
|
|
|
34,832 |
|
|
|
6,050 |
|
|
|
40,882 |
|
|
|
Currencies |
|
|
|
|
|
|
96,959 |
|
|
|
189 |
|
|
|
97,148 |
|
|
|
Commodities |
|
|
|
|
|
|
20,087 |
|
|
|
587 |
|
|
|
20,674 |
|
|
|
Equities |
|
|
46 |
|
|
|
46,491 |
|
|
|
623 |
|
|
|
47,160 |
|
Gross fair value of derivative assets |
|
|
50 |
|
|
|
766,130 |
|
|
|
8,009 |
|
|
|
774,189 |
|
|
|
Counterparty netting within levels |
|
|
|
|
|
|
(627,548 |
) |
|
|
(2,139 |
) |
|
|
(629,687 |
) |
Subtotal |
|
|
$ 50 |
|
|
|
$ 138,582 |
|
|
|
$ 5,870 |
|
|
|
$ 144,502 |
|
|
|
Cross-level counterparty netting |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,480 |
) |
|
|
Cash collateral netting |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(89,132 |
) |
Fair value included in financial
instruments owned |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 53,890 |
|
Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rates |
|
|
$(11 |
) |
|
|
$(513,275 |
) |
|
|
$ (958 |
) |
|
|
$(514,244 |
) |
|
|
Credit |
|
|
|
|
|
|
(33,518 |
) |
|
|
(3,257 |
) |
|
|
(36,775 |
) |
|
|
Currencies |
|
|
|
|
|
|
(99,377 |
) |
|
|
(223 |
) |
|
|
(99,600 |
) |
|
|
Commodities |
|
|
|
|
|
|
(20,222 |
) |
|
|
(849 |
) |
|
|
(21,071 |
) |
|
|
Equities |
|
|
(18 |
) |
|
|
(43,953 |
) |
|
|
(2,227 |
) |
|
|
(46,198 |
) |
Gross fair value of derivative liabilities |
|
|
(29 |
) |
|
|
(710,345 |
) |
|
|
(7,514 |
) |
|
|
(717,888 |
) |
|
|
Counterparty netting within levels |
|
|
|
|
|
|
627,548 |
|
|
|
2,139 |
|
|
|
629,687 |
|
Subtotal |
|
|
$(29 |
) |
|
|
$ (82,797 |
) |
|
|
$(5,375 |
) |
|
|
$ (88,201 |
) |
|
|
Cross-level counterparty netting |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,480 |
|
|
|
Cash collateral netting |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
39,950 |
|
Fair value included in financial instruments sold,
but not yet purchased |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ (46,771 |
) |
In the tables above:
|
|
The gross fair values exclude the effects of both counterparty netting and collateral netting, and therefore
are not representative of the firms exposure. |
|
|
Counterparty netting is reflected in each level to the extent that receivable and payable balances are netted
within the same level and is included in Counterparty netting within levels. Where the counterparty netting is across levels, the netting is reflected in Cross-level counterparty netting. |
|
|
Derivative assets are shown as positive amounts and derivative liabilities are shown as negative amounts.
|
|
|
|
|
|
26 |
|
Goldman Sachs March 2016 Form 10-Q |
|
|
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Significant Unobservable Inputs
The table below presents the amount of level 3 assets (liabilities), and ranges, averages and
medians of significant unobservable inputs used to value the firms level 3 derivatives.
|
|
|
|
|
|
|
|
|
|
|
Level 3 Assets (Liabilities) and Range of Significant
Unobservable Inputs (Average / Median) as of |
|
$ in millions |
|
|
March 2016 |
|
|
|
December 2015 |
|
Interest Rates |
|
|
$(383) |
|
|
|
$(398) |
|
|
|
Correlation |
|
|
(10)% to 86% (56% / 60%) |
|
|
|
(25)% to 92% (53% / 55%) |
|
|
|
Volatility (bps per annum) |
|
|
31 to 151 (84 / 57) |
|
|
|
31 to 152 (84 / 57) |
|
Credit |
|
|
$2,821 |
|
|
|
$2,793 |
|
|
|
Correlation |
|
|
35% to 90% (63% / 62%) |
|
|
|
46% to 99% (68% / 66%) |
|
|
|
Credit Spreads (bps) |
|
|
1 to 909 (147 / 87) |
1 |
|
|
1 to 1,019 (129 / 86) |
1 |
|
|
Upfront Credit Points |
|
|
0 to 99 (41 / 37) |
|
|
|
0 to 100 (41 / 40) |
|
|
|
Recovery Rates |
|
|
20% to 75% (58% / 70%) |
|
|
|
2% to 97% (58% / 70%) |
|
Currencies |
|
|
$9 |
|
|
|
$(34) |
|
|
|
Correlation |
|
|
25% to 70% (51% / 55%) |
|
|
|
25% to 70% (50% / 51%) |
|
Commodities |
|
|
$(291) |
|
|
|
$(262) |
|
|
|
Volatility |
|
|
15% to 65% (37% / 37%) |
|
|
|
11% to 77% (35% / 34%) |
|
|
|
Spread per million British thermal units of natural gas |
|
|
$(1.38) to $3.97 ($(0.07) / $(0.03)) |
|
|
|
$(1.32) to $4.15 ($(0.05) / $(0.01)) |
|
|
|
Spread per barrel of oil and refined products |
|
|
$(12.60) to $63.72 ($7.54 / $8.96) |
|
|
|
$(10.64) to $65.29 ($3.34 /$(3.31)) |
1 |
Equities |
|
|
$(2,101) |
|
|
|
$(1,604) |
|
|
|
Correlation |
|
|
(30)% to 91% (40% / 46%) |
|
|
|
(65)% to 94% (42% / 48%) |
|
|
|
Volatility |
|
|
5% to 105% (28% / 25%) |
|
|
|
5% to 76% (24% / 23%) |
|
1. |
The difference between the average and the median for these spread inputs indicates that the majority of the inputs fall
in the lower end of the range. |
In the table above:
|
|
Ranges represent the significant unobservable inputs that were used in the valuation of each type of
derivative. |
|
|
Averages represent the arithmetic average of the inputs and are not weighted by the relative fair value or
notional of the respective financial instruments. An average greater than the median indicates that the majority of inputs are below the average. |
|
|
The ranges, averages and medians of these inputs are not representative of the appropriate inputs to use when
calculating the fair value of any one derivative. For example, the highest correlation for interest rate derivatives is appropriate for valuing a specific interest rate derivative but may not be appropriate for valuing any other interest rate
derivative. Accordingly, the ranges of inputs do not represent uncertainty in, or possible ranges of, fair value measurements of the firms level 3 derivatives. |
|
|
Interest rates, currencies and equities derivatives are valued using option pricing models, credit derivatives
are valued using option pricing, correlation and discounted cash flow models, and commodities derivatives are valued using option pricing and discounted cash flow models. |
|
|
The fair value of any one instrument may be determined using multiple valuation techniques. For example,
option pricing models and discounted cash flows models are typically used together to determine fair value. Therefore, the level 3 balance encompasses both of these techniques. |
|
|
Correlation within currencies and equities includes cross-product correlation. |
|
|
Derivative assets are shown as positive amounts and derivative liabilities are shown as negative amounts.
|
|
|
|
|
|
|
|
Goldman Sachs March 2016 Form 10-Q |
|
27 |
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Range of Significant Unobservable Inputs
The following is information about the ranges of significant unobservable inputs used to value the firms level 3 derivative
instruments:
|
|
Correlation. Ranges for correlation cover a variety of
underliers both within one market (e.g., equity index and equity single stock names) and across markets (e.g., correlation of an interest rate and a foreign exchange rate), as well as across regions. Generally, cross-product correlation inputs
are used to value more complex instruments and are lower than correlation inputs on assets within the same derivative product type. |
|
|
Volatility. Ranges for volatility cover numerous underliers
across a variety of markets, maturities and strike prices. For example, volatility of equity indices is generally lower than volatility of single stocks. |
|
|
Credit spreads, upfront credit points and recovery rates. The
ranges for credit spreads, upfront credit points and recovery rates cover a variety of underliers (index and single names), regions, sectors, maturities and credit qualities (high-yield and investment-grade). The broad range of this population gives
rise to the width of the ranges of significant unobservable inputs. |
|
|
Commodity prices and spreads. The ranges for commodity prices
and spreads cover variability in products, maturities and locations.
|
Sensitivity of Fair Value Measurement to Changes in Significant Unobservable Inputs
The following is a description of the directional sensitivity of the firms level 3 fair value measurements to changes in significant
unobservable inputs, in isolation:
|
|
Correlation. In general, for contracts where the holder benefits
from the convergence of the underlying asset or index prices (e.g., interest rates, credit spreads, foreign exchange rates, inflation rates and equity prices), an increase in correlation results in a higher fair value measurement.
|
|
|
Volatility. In general, for purchased options, an increase in
volatility results in a higher fair value measurement. |
|
|
Credit spreads, upfront credit points and recovery rates. In
general, the fair value of purchased credit protection increases as credit spreads or upfront credit points increase or recovery rates decrease. Credit spreads, upfront credit points and recovery rates are strongly related to distinctive risk
factors of the underlying reference obligations, which include reference entity-specific factors such as leverage, volatility and industry, market-based risk factors, such as borrowing costs or liquidity of the underlying reference obligation, and
macroeconomic conditions. |
|
|
Commodity prices and spreads. In general, for contracts where
the holder is receiving a commodity, an increase in the spread (price difference from a benchmark index due to differences in quality or delivery location) or price results in a higher fair value measurement. |
Due to the distinctive nature of each of the firms level 3 derivatives, the interrelationship of inputs is not necessarily uniform
within each product type.
|
|
|
|
|
28 |
|
Goldman Sachs March 2016 Form 10-Q |
|
|
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Level 3 Rollforward
The table below presents changes in fair value for all derivatives categorized as level 3
as of the end of the period. In the table below:
|
|
If a derivative was transferred to level 3 during a reporting period, its entire gain or loss for the
period is included in level 3. Transfers between levels are reported at the beginning of the reporting period in which they occur. |
|
|
Positive amounts for transfers into level 3 and negative amounts for transfers out of level 3
represent net transfers of derivative assets. Negative amounts for transfers into level 3 and positive amounts for transfers out of level 3 represent net transfers of derivative liabilities. |
|
|
A derivative with level 1 and/or level 2 inputs is classified in level 3 in its entirety if it
has at least one significant level 3 input. |
|
|
If there is one significant level 3 input, the entire gain or loss from adjusting only observable inputs
(i.e., level 1 and level 2 inputs) is classified as level 3. |
|
|
Gains or losses that have been reported in level 3 resulting from changes in level 1 or level 2
inputs are frequently offset by gains or losses attributable to level 1 or level 2 derivatives and/or level 1, level 2 and level 3 cash instruments. As a result, gains/(losses) included in the level 3 rollforward below
do not necessarily represent the overall impact on the firms results of operations, liquidity or capital resources.
|
|
|
Net unrealized gains/(losses) relate to instruments that were still held at period-end. |
|
|
For the three months ended March 2016, the net realized and unrealized gains on level 3 derivative
assets and liabilities of $382 million (reflecting $79 million of realized losses and $461 million of unrealized gains) include gains/(losses) of $393 million and $(11) million reported in Market making and
Other principal transactions respectively. |
|
|
For the three months ended March 2015, the net realized and unrealized gains on level 3 derivative
assets and liabilities of $749 million (reflecting $113 million of realized gains and $636 million of unrealized gains) include gains/(losses) of $784 million and $(35) million reported in Market making and
Other principal transactions respectively. |
|
|
See Level 3 Rollforward Commentary below for an explanation of the net unrealized
gains/(losses) on level 3 derivative assets and liabilities and the activity related to transfers into and out of level 3.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Level 3 Derivative Assets and Liabilities at Fair Value |
|
$ in millions |
|
|
Asset/ (liability) balance, beginning of period |
|
|
|
Net realized gains/ (losses) |
|
|
|
Net unrealized gains/ (losses) |
|
|
|
Purchases |
|
|
|
Sales |
|
|
|
Settlements |
|
|
|
Transfers into level 3 |
|
|
|
Transfers out of level 3 |
|
|
|
Asset/ (liability) balance, end of period |
|
Three Months Ended March 2016 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rates net |
|
|
$ (398 |
) |
|
|
$ (11 |
) |
|
|
$ 28 |
|
|
|
$ 3 |
|
|
|
$ (10 |
) |
|
|
$ 17 |
|
|
|
$ |
|
|
|
$ (12 |
) |
|
|
$ (383 |
) |
|
|
Credit net |
|
|
2,793 |
|
|
|
(26 |
) |
|
|
210 |
|
|
|
33 |
|
|
|
(57 |
) |
|
|
(75 |
) |
|
|
8 |
|
|
|
(65 |
) |
|
|
2,821 |
|
|
|
Currencies net |
|
|
(34 |
) |
|
|
(21 |
) |
|
|
(5 |
) |
|
|
6 |
|
|
|
(1 |
) |
|
|
61 |
|
|
|
|
|
|
|
3 |
|
|
|
9 |
|
|
|
Commodities net |
|
|
(262 |
) |
|
|
(5 |
) |
|
|
41 |
|
|
|
47 |
|
|
|
(18 |
) |
|
|
(37 |
) |
|
|
(26 |
) |
|
|
(31 |
) |
|
|
(291 |
) |
|
|
Equities net |
|
|
(1,604 |
) |
|
|
(16 |
) |
|
|
187 |
|
|
|
26 |
|
|
|
(1,739 |
) |
|
|
140 |
|
|
|
2 |
|
|
|
903 |
|
|
|
(2,101 |
) |
Total derivatives net |
|
|
$ 495 |
|
|
|
$ (79 |
) |
|
|
$461 |
|
|
|
$115 |
|
|
|
$(1,825 |
) |
|
|
$ 106 |
|
|
|
$ (16 |
) |
|
|
$ 798 |
|
|
|
$ 55 |
|
Three Months Ended
March 2015 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rates net |
|
|
$ (40 |
) |
|
|
$ (8 |
) |
|
|
$ 85 |
|
|
|
$ 23 |
|
|
|
$ (22 |
) |
|
|
$ 4 |
|
|
|
$ (27 |
) |
|
|
$ (51 |
) |
|
|
$ (36 |
) |
|
|
Credit net |
|
|
3,530 |
|
|
|
134 |
|
|
|
479 |
|
|
|
58 |
|
|
|
(132 |
) |
|
|
(507 |
) |
|
|
286 |
|
|
|
(259 |
) |
|
|
3,589 |
|
|
|
Currencies net |
|
|
(267 |
) |
|
|
(31 |
) |
|
|
30 |
|
|
|
8 |
|
|
|
(4 |
) |
|
|
85 |
|
|
|
5 |
|
|
|
(8 |
) |
|
|
(182 |
) |
|
|
Commodities net |
|
|
(1,142 |
) |
|
|
7 |
|
|
|
(49 |
) |
|
|
|
|
|
|
(10 |
) |
|
|
6 |
|
|
|
(9 |
) |
|
|
(189 |
) |
|
|
(1,386 |
) |
|
|
Equities net |
|
|
(1,375 |
) |
|
|
11 |
|
|
|
91 |
|
|
|
41 |
|
|
|
(553 |
) |
|
|
804 |
|
|
|
27 |
|
|
|
180 |
|
|
|
(774 |
) |
Total derivatives net |
|
|
$ 706 |
|
|
|
$113 |
|
|
|
$636 |
|
|
|
$130 |
|
|
|
$ (721 |
) |
|
|
$ 392 |
|
|
|
$282 |
|
|
|
$(327 |
) |
|
|
$ 1,211 |
|
|
|
|
|
|
|
|
Goldman Sachs March 2016 Form 10-Q |
|
29 |
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Level 3 Rollforward Commentary
Three Months ended March 2016. The net unrealized
gain on level 3 derivatives of $461 million for the three months ended March 2016 was primarily attributable to gains on certain credit derivatives, reflecting the impact of changes in interest rates and widening of certain credit
spreads, and gains on certain equity derivatives, reflecting the impact of changes in equity prices.
Transfers out of level 3
derivatives during the three months ended March 2016 primarily reflected transfers of certain equity derivative liabilities to level 2, principally due to certain unobservable inputs no longer being significant to the valuation of these
derivatives.
Three Months Ended March 2015.
The net unrealized gain on level 3 derivatives of $636 million for the three months ended March 2015 was primarily attributable to gains on credit derivatives, primarily reflecting the impact of a decrease in interest rates, changes
in foreign exchange rates and wider credit spreads.
Transfers into level 3 derivatives during the three months ended
March 2015 primarily reflected transfers of certain credit derivative assets from level 2, principally due to unobservable credit spread inputs becoming significant to the valuation of certain derivatives and to the net risk of certain
portfolios.
Transfers out of level 3 derivatives during the three months ended March 2015 primarily reflected transfers of
certain credit derivative assets to level 2, principally due to increased transparency of correlation and upfront credit point inputs used to value these derivatives, transfers of certain commodity derivative assets to level 2, principally
due to increased transparency of natural gas spread inputs used to value these derivatives and unobservable volatility inputs no longer being significant to the valuation of certain other commodity derivatives and transfers of certain equity
derivative liabilities to level 2, principally due to unobservable inputs no longer being significant to the valuation of these derivatives.
OTC Derivatives
The table below presents the fair values of OTC derivative assets and liabilities by tenor and major product type.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ in millions |
|
|
Less than 1 Year |
|
|
|
1 - 5 Years |
|
|
|
Greater than 5 Years |
|
|
|
Total |
|
As of March 2016 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rates |
|
|
$ 5,106 |
|
|
|
$26,561 |
|
|
|
$ 93,300 |
|
|
|
$124,967 |
|
|
|
Credit |
|
|
1,621 |
|
|
|
4,022 |
|
|
|
6,575 |
|
|
|
12,218 |
|
|
|
Currencies |
|
|
15,721 |
|
|
|
7,668 |
|
|
|
7,442 |
|
|
|
30,831 |
|
|
|
Commodities |
|
|
5,199 |
|
|
|
2,925 |
|
|
|
228 |
|
|
|
8,352 |
|
|
|
Equities |
|
|
5,299 |
|
|
|
7,537 |
|
|
|
1,986 |
|
|
|
14,822 |
|
|
|
Counterparty netting within tenors |
|
|
(3,737 |
) |
|
|
(5,868 |
) |
|
|
(5,387 |
) |
|
|
(14,992 |
) |
Subtotal |
|
|
$29,209 |
|
|
|
$42,845 |
|
|
|
$104,144 |
|
|
|
$176,198 |
|
|
|
Cross-tenor counterparty netting |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(25,354 |
) |
|
|
Cash collateral netting |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(93,916 |
) |
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 56,928 |
|
Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rates |
|
|
$ 6,871 |
|
|
|
$15,388 |
|
|
|
$ 47,096 |
|
|
|
$ 69,355 |
|
|
|
Credit |
|
|
2,370 |
|
|
|
3,827 |
|
|
|
1,826 |
|
|
|
8,023 |
|
|
|
Currencies |
|
|
17,616 |
|
|
|
9,389 |
|
|
|
8,904 |
|
|
|
35,909 |
|
|
|
Commodities |
|
|
4,593 |
|
|
|
1,985 |
|
|
|
2,613 |
|
|
|
9,191 |
|
|
|
Equities |
|
|
8,606 |
|
|
|
5,767 |
|
|
|
2,497 |
|
|
|
16,870 |
|
|
|
Counterparty netting within tenors |
|
|
(3,737 |
) |
|
|
(5,868 |
) |
|
|
(5,387 |
) |
|
|
(14,992 |
) |
Subtotal |
|
|
$36,319 |
|
|
|
$30,488 |
|
|
|
$ 57,549 |
|
|
|
$124,356 |
|
|
|
Cross-tenor counterparty netting |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(25,354 |
) |
|
|
Cash collateral netting |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(47,739 |
) |
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 51,263 |
|
As of December 2015 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rates |
|
|
$ 4,231 |
|
|
|
$23,278 |
|
|
|
$ 81,401 |
|
|
|
$108,910 |
|
|
|
Credit |
|
|
1,664 |
|
|
|
4,547 |
|
|
|
5,842 |
|
|
|
12,053 |
|
|
|
Currencies |
|
|
14,646 |
|
|
|
8,936 |
|
|
|
6,353 |
|
|
|
29,935 |
|
|
|
Commodities |
|
|
6,228 |
|
|
|
3,897 |
|
|
|
231 |
|
|
|
10,356 |
|
|
|
Equities |
|
|
4,806 |
|
|
|
7,091 |
|
|
|
1,550 |
|
|
|
13,447 |
|
|
|
Counterparty netting within tenors |
|
|
(3,660 |
) |
|
|
(5,751 |
) |
|
|
(5,270 |
) |
|
|
(14,681 |
) |
Subtotal |
|
|
$27,915 |
|
|
|
$41,998 |
|
|
|
$ 90,107 |
|
|
|
$160,020 |
|
|
|
Cross-tenor counterparty netting |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(20,462 |
) |
|
|
Cash collateral netting |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(89,132 |
) |
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$50,426 |
|
Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rates |
|
|
$ 5,323 |
|
|
|
$13,945 |
|
|
|
$ 35,592 |
|
|
|
$ 54,860 |
|
|
|
Credit |
|
|
1,804 |
|
|
|
4,704 |
|
|
|
1,437 |
|
|
|
7,945 |
|
|
|
Currencies |
|
|
12,378 |
|
|
|
9,940 |
|
|
|
10,048 |
|
|
|
32,366 |
|
|
|
Commodities |
|
|
4,464 |
|
|
|
3,136 |
|
|
|
2,526 |
|
|
|
10,126 |
|
|
|
Equities |
|
|
5,154 |
|
|
|
5,802 |
|
|
|
2,994 |
|
|
|
13,950 |
|
|
|
Counterparty netting within tenors |
|
|
(3,660 |
) |
|
|
(5,751 |
) |
|
|
(5,270 |
) |
|
|
(14,681 |
) |
Subtotal |
|
|
$25,463 |
|
|
|
$31,776 |
|
|
|
$ 47,327 |
|
|
|
$104,566 |
|
|
|
Cross-tenor counterparty netting |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(20,462 |
) |
|
|
Cash collateral netting |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(39,950 |
) |
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 44,154 |
|
|
|
|
|
|
30 |
|
Goldman Sachs March 2016 Form 10-Q |
|
|
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
In the table above:
|
|
Tenor is based on expected duration for mortgage-related credit derivatives and generally on remaining
contractual maturity for other derivatives. |
|
|
Counterparty netting within the same product type and tenor category is included within such product type and
tenor category. |
|
|
Counterparty netting across product types within the same tenor category is included in Counterparty
netting within tenors. Where the counterparty netting is across tenor categories, the netting is reflected in Cross-tenor counterparty netting. |
Credit Derivatives
The firm enters into a broad
array of credit derivatives in locations around the world to facilitate client transactions and to manage the credit risk associated with market-making and investing and lending activities. Credit derivatives are actively managed based on the
firms net risk position.
Credit derivatives are individually negotiated contracts and can have various settlement and payment
conventions. Credit events include failure to pay, bankruptcy, acceleration of indebtedness, restructuring, repudiation and dissolution of the reference entity.
The firm enters into the following types of credit derivatives:
|
|
Credit Default Swaps. Single-name credit default swaps protect
the buyer against the loss of principal on one or more bonds, loans or mortgages (reference obligations) in the event the issuer (reference entity) of the reference obligations suffers a credit event. The buyer of protection pays an initial or
periodic premium to the seller and receives protection for the period of the contract. If there is no credit event, as defined in the contract, the seller of protection makes no payments to the buyer of protection. However, if a credit event occurs,
the seller of protection is required to make a payment to the buyer of protection, which is calculated in accordance with the terms of the contract. |
|
|
Credit Options. In a credit option, the option writer assumes
the obligation to purchase or sell a reference obligation at a specified price or credit spread. The option purchaser buys the right, but does not assume the obligation, to sell the reference obligation to, or purchase it from, the option writer.
The payments on credit options depend either on a particular credit spread or the price of the reference obligation.
|
|
|
Credit Indices, Baskets and Tranches. Credit derivatives may
reference a basket of single-name credit default swaps or a broad-based index. If a credit event occurs in one of the underlying reference obligations, the protection seller pays the protection buyer. The payment is typically a pro-rata portion of
the transactions total notional amount based on the underlying defaulted reference obligation. In certain transactions, the credit risk of a basket or index is separated into various portions (tranches), each having different levels of
subordination. The most junior tranches cover initial defaults and once losses exceed the notional amount of these junior tranches, any excess loss is covered by the next most senior tranche in the capital structure. |
|
|
Total Return Swaps. A total return swap transfers the risks
relating to economic performance of a reference obligation from the protection buyer to the protection seller. Typically, the protection buyer receives from the protection seller a floating rate of interest and protection against any reduction in
fair value of the reference obligation, and in return the protection seller receives the cash flows associated with the reference obligation, plus any increase in the fair value of the reference obligation. |
The firm economically hedges its exposure to written credit derivatives primarily by entering into offsetting purchased credit derivatives with
identical underliers. Substantially all of the firms purchased credit derivative transactions are with financial institutions and are subject to stringent collateral thresholds. In addition, upon the occurrence of a specified trigger event,
the firm may take possession of the reference obligations underlying a particular written credit derivative, and consequently may, upon liquidation of the reference obligations, recover amounts on the underlying reference obligations in the event of
default.
As of March 2016, written and purchased credit derivatives had total gross notional amounts of $970.66 billion and
$1.01 trillion, respectively, for total net notional purchased protection of $38.60 billion. As of December 2015, written and purchased credit derivatives had total gross notional amounts of $923.48 billion and
$968.68 billion, respectively, for total net notional purchased protection of $45.20 billion. Substantially all of the firms written and purchased credit derivatives are credit default swaps.
|
|
|
|
|
|
|
Goldman Sachs March 2016 Form 10-Q |
|
31 |
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
The table below presents certain information about credit derivatives.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit Spread on Underlier (basis points) |
|
$ in millions |
|
0 - 250 |
|
|
251 -
500 |
|
|
501 - 1,000 |
|
|
Greater than 1,000 |
|
|
Total |
|
As of
March 2016 |
|
Maximum Payout/Notional
Amount of Written Credit Derivatives by Tenor |
|
Less than 1 year |
|
|
$241,215 |
|
|
|
$ 6,035 |
|
|
|
$ 2,678 |
|
|
|
$ 8,852 |
|
|
|
$258,780 |
|
|
|
1 - 5 years |
|
|
525,268 |
|
|
|
36,418 |
|
|
|
17,789 |
|
|
|
21,490 |
|
|
|
600,965 |
|
|
|
Greater than 5 years |
|
|
92,695 |
|
|
|
12,286 |
|
|
|
4,343 |
|
|
|
1,595 |
|
|
|
110,919 |
|
Total |
|
|
$859,178 |
|
|
|
$54,739 |
|
|
|
$24,810 |
|
|
|
$ 31,937 |
|
|
|
$970,664 |
|
Maximum Payout/Notional
Amount of Purchased Credit Derivatives |
|
Offsetting |
|
|
$766,408 |
|
|
|
$46,382 |
|
|
|
$17,797 |
|
|
|
$ 22,474 |
|
|
|
$853,061 |
|
|
|
Other |
|
|
127,323 |
|
|
|
10,073 |
|
|
|
8,313 |
|
|
|
10,493 |
|
|
|
156,202 |
|
Fair Value of Written
Credit Derivatives |
|
Asset |
|
|
$ 16,961 |
|
|
|
$ 961 |
|
|
|
$ 180 |
|
|
|
$ 111 |
|
|
|
$ 18,213 |
|
|
|
Liability |
|
|
3,427 |
|
|
|
2,163 |
|
|
|
1,787 |
|
|
|
10,339 |
|
|
|
17,716 |
|
Net asset/(liability) |
|
|
$ 13,534 |
|
|
|
$ (1,202 |
) |
|
|
$ (1,607 |
) |
|
|
$(10,228 |
) |
|
|
$ 497 |
|
As of
December 2015 |
|
Maximum Payout/Notional
Amount of Written Credit Derivatives by Tenor |
|
Less than 1 year |
|
|
$240,468 |
|
|
|
$ 2,859 |
|
|
|
$ 2,881 |
|
|
|
$ 10,533 |
|
|
|
$256,741 |
|
|
|
1 - 5 years |
|
|
514,986 |
|
|
|
42,399 |
|
|
|
16,327 |
|
|
|
26,271 |
|
|
|
599,983 |
|
|
|
Greater than 5 years |
|
|
57,054 |
|
|
|
6,481 |
|
|
|
1,567 |
|
|
|
1,651 |
|
|
|
66,753 |
|
Total |
|
|
$812,508 |
|
|
|
$51,739 |
|
|
|
$20,775 |
|
|
|
$ 38,455 |
|
|
|
$923,477 |
|
Maximum Payout/Notional
Amount of Purchased Credit Derivatives |
|
Offsetting |
|
|
$722,436 |
|
|
|
$46,313 |
|
|
|
$19,556 |
|
|
|
$ 33,266 |
|
|
|
$821,571 |
|
|
|
Other |
|
|
132,757 |
|
|
|
6,383 |
|
|
|
3,372 |
|
|
|
4,598 |
|
|
|
147,110 |
|
Fair Value of Written
Credit Derivatives |
|
Asset |
|
|
$ 17,110 |
|
|
|
$ 924 |
|
|
|
$ 108 |
|
|
|
$ 190 |
|
|
|
$ 18,332 |
|
|
|
Liability |
|
|
2,756 |
|
|
|
2,596 |
|
|
|
1,942 |
|
|
|
12,485 |
|
|
|
19,779 |
|
Net asset/(liability) |
|
|
$ 14,354 |
|
|
|
$ (1,672 |
) |
|
|
$ (1,834 |
) |
|
|
$(12,295 |
) |
|
|
$ (1,447 |
) |
In the table above:
|
|
Fair values exclude the effects of both netting of receivable balances with payable balances under enforceable
netting agreements, and netting of cash received or posted under enforceable credit support agreements, and therefore are not representative of the firms credit exposure. |
|
|
Tenor is based on expected duration for mortgage-related credit derivatives and on remaining contractual
maturity for other credit derivatives. |
|
|
The credit spread on the underlier, together with the tenor of the contract, are indicators of
payment/performance risk. The firm is less likely to pay or otherwise be required to perform where the credit spread and the tenor are lower. |
|
|
Offsetting purchased credit derivatives represent the notional amount of purchased credit derivatives that
economically hedge written credit derivatives with identical underliers and are included in Offsetting. |
|
|
Other purchased credit derivatives represent the notional amount of all other purchased credit derivatives not
included in Offsetting. |
Impact of Credit Spreads on Derivatives
On an ongoing basis, the firm realizes gains or losses relating to changes in credit risk through the unwind of derivative contracts and
changes in credit mitigants.
The net gain/(loss), including hedges, attributable to the impact of changes in credit exposure and credit
spreads (counterparty and the firms) on derivatives was $132 million and $(99) million for the three months ended March 2016 and March 2015, respectively.
Bifurcated Embedded Derivatives
The table below
presents the fair value and the notional amount of derivatives that have been bifurcated from their related borrowings. These derivatives, which are recorded at fair value, primarily consist of interest rate, equity and commodity products and are
included in Unsecured short-term borrowings and Unsecured long-term borrowings with the related borrowings. See Note 8 for further information.
|
|
|
|
|
|
|
|
|
|
|
As of |
|
$ in millions |
|
|
March 2016 |
|
|
|
December 2015 |
|
Fair value of assets |
|
|
$ 600 |
|
|
|
$ 466 |
|
|
|
Fair value of liabilities |
|
|
668 |
|
|
|
794 |
|
Net liability |
|
|
$ 68 |
|
|
|
$ 328 |
|
Notional amount |
|
|
$9,235 |
|
|
|
$7,869 |
|
Derivatives with Credit-Related Contingent Features
Certain of the firms derivatives have been transacted under bilateral agreements with counterparties who may require the firm to post
collateral or terminate the transactions based on changes in the firms credit ratings. The firm assesses the impact of these bilateral agreements by determining the collateral or termination payments that would occur assuming a downgrade by
all rating agencies. A downgrade by any one rating agency, depending on the agencys relative ratings of the firm at the time of the downgrade, may have an impact which is comparable to the impact of a downgrade by all rating agencies.
|
|
|
|
|
32 |
|
Goldman Sachs March 2016 Form 10-Q |
|
|
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
The table below presents the aggregate fair value of net derivative liabilities under such
agreements (excluding application of collateral posted to reduce these liabilities), the related aggregate fair value of the assets posted as collateral and the additional collateral or termination payments that could have been called at the
reporting date by counterparties in the event of a one-notch and two-notch downgrade in the firms credit ratings.
|
|
|
|
|
|
|
|
|
|
|
As of |
|
$ in millions |
|
|
March 2016 |
|
|
|
December 2015 |
|
Net derivative liabilities under bilateral agreements |
|
|
$36,752 |
|
|
|
$29,836 |
|
|
|
Collateral posted |
|
|
31,979 |
|
|
|
26,075 |
|
|
|
Additional collateral or termination payments for a one-notch downgrade |
|
|
676 |
|
|
|
1,061 |
|
|
|
Additional collateral or termination payments for a two-notch
downgrade |
|
|
2,031 |
|
|
|
2,689 |
|
Hedge Accounting
The firm applies hedge accounting for (i) certain interest rate swaps used to manage the interest rate exposure of certain fixed-rate
unsecured long-term and short-term borrowings and certain fixed-rate certificates of deposit and (ii) certain foreign currency forward contracts and foreign currency-denominated debt used to manage foreign currency exposures on the firms
net investment in certain non-U.S. operations.
To qualify for hedge accounting, the hedging instrument must be highly effective at
reducing the risk from the exposure being hedged. Additionally, the firm must formally document the hedging relationship at inception and test the hedging relationship at least on a quarterly basis to ensure the hedging instrument continues to be
highly effective over the life of the hedging relationship.
Fair Value Hedges
The firm designates certain interest rate swaps as fair value hedges. These interest rate swaps hedge changes in fair value attributable to the
designated benchmark interest rate (e.g., London Interbank Offered Rate (LIBOR) or Overnight Index Swap Rate (OIS)), effectively converting a substantial portion of fixed-rate obligations into floating-rate obligations.
The firm applies a statistical method that utilizes regression analysis when assessing the effectiveness of its fair value hedging
relationships in achieving offsetting changes in the fair values of the hedging instrument and the risk being hedged (i.e., interest rate risk). An interest rate swap is considered highly effective in offsetting changes in fair value attributable to
changes in the hedged risk when the regression analysis results in a coefficient of determination of 80% or greater and a slope between 80% and 125%.
For qualifying fair value hedges, gains or losses on derivatives are included in Interest
expense. The change in fair value of the hedged item attributable to the risk being hedged is reported as an adjustment to its carrying value and is subsequently amortized into interest expense over its remaining life. Gains or losses
resulting from hedge ineffectiveness are included in Interest expense. When a derivative is no longer designated as a hedge, any remaining difference between the carrying value and par value of the hedged item is amortized to interest
expense over the remaining life of the hedged item using the effective interest method. See Note 23 for further information about interest income and interest expense.
The table below presents the gains/(losses) from interest rate derivatives accounted for as hedges, the related hedged borrowings and bank
deposits, and the hedge ineffectiveness on these derivatives, which primarily consists of amortization of prepaid credit spreads resulting from the passage of time.
|
|
|
|
|
|
|
|
|
|
|
Three Months
Ended March |
|
$ in millions |
|
|
2016 |
|
|
|
2015 |
|
Interest rate hedges |
|
|
$ 1,990 |
|
|
|
$ 942 |
|
|
|
Hedged borrowings and bank deposits |
|
|
(2,028 |
) |
|
|
(1,050 |
) |
Hedge ineffectiveness |
|
|
$ (38 |
) |
|
|
$ (108 |
) |
Net Investment Hedges
The firm seeks to reduce the impact of fluctuations in foreign exchange rates on its net investments in certain non-U.S. operations through the
use of foreign currency forward contracts and foreign currency-denominated debt. For foreign currency forward contracts designated as hedges, the effectiveness of the hedge is assessed based on the overall changes in the fair value of the forward
contracts (i.e., based on changes in forward rates). For foreign currency-denominated debt designated as a hedge, the effectiveness of the hedge is assessed based on changes in spot rates.
For qualifying net investment hedges, the gains or losses on the hedging instruments, to the extent effective, are included in Currency
translation in the condensed consolidated statements of comprehensive income.
The table below presents the gains/(losses) from net
investment hedging.
|
|
|
|
|
|
|
|
|
|
|
Three Months
Ended March |
|
$ in millions |
|
|
2016 |
|
|
|
2015 |
|
Foreign currency forward contract hedges |
|
|
$ (356 |
) |
|
|
$ 444 |
|
|
|
Foreign currency-denominated debt hedges |
|
|
(150 |
) |
|
|
2 |
|
|
|
|
|
|
|
|
Goldman Sachs March 2016 Form 10-Q |
|
33 |
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
The gain/(loss) related to ineffectiveness and the gain/(loss) reclassified to earnings from
accumulated other comprehensive loss were not material for the three months ended March 2016 or March 2015.
As of
March 2016 and December 2015, the firm had designated $2.36 billion and $2.20 billion, respectively, of foreign currency-denominated debt, included in Unsecured long-term borrowings and Unsecured short-term
borrowings, as hedges of net investments in non-U.S. subsidiaries.
Note 8.
Fair Value Option
Other Financial Assets and Financial
Liabilities at Fair Value
In addition to all cash and derivative instruments included in Financial instruments owned, at fair
value and Financial instruments sold, but not yet purchased, at fair value, the firm accounts for certain of its other financial assets and financial liabilities at fair value primarily under the fair value option. The primary
reasons for electing the fair value option are to:
|
|
Reflect economic events in earnings on a timely basis; |
|
|
Mitigate volatility in earnings from using different measurement attributes (e.g., transfers of financial
instruments owned accounted for as financings are recorded at fair value whereas the related secured financing would be recorded on an accrual basis absent electing the fair value option); and |
|
|
Address simplification and cost-benefit considerations (e.g., accounting for hybrid financial instruments at
fair value in their entirety versus bifurcation of embedded derivatives and hedge accounting for debt hosts).
|
Hybrid financial instruments are instruments that contain bifurcatable embedded derivatives and
do not require settlement by physical delivery of non-financial assets (e.g., physical commodities). If the firm elects to bifurcate the embedded derivative from the associated debt, the derivative is accounted for at fair value and the host
contract is accounted for at amortized cost, adjusted for the effective portion of any fair value hedges. If the firm does not elect to bifurcate, the entire hybrid financial instrument is accounted for at fair value under the fair value option.
Other financial assets and financial liabilities accounted for at fair value under the fair value option include:
|
|
Repurchase agreements and substantially all resale agreements; |
|
|
Securities borrowed and loaned within Fixed Income, Currency and Commodities Client Execution;
|
|
|
Substantially all other secured financings, including transfers of assets accounted for as financings rather
than sales; |
|
|
Certain unsecured short-term borrowings, consisting of all commercial paper and certain hybrid financial
instruments; |
|
|
Certain unsecured long-term borrowings, including certain prepaid commodity transactions and certain hybrid
financial instruments; |
|
|
Certain receivables from customers and counterparties, including transfers of assets accounted for as secured
loans rather than purchases and certain margin loans; |
|
|
Certain time deposits issued by the firms bank subsidiaries (deposits with no stated maturity are not
eligible for a fair value option election), including structured certificates of deposit, which are hybrid financial instruments; and |
|
|
Certain subordinated liabilities issued by consolidated VIEs.
|
|
|
|
|
|
34 |
|
Goldman Sachs March 2016 Form 10-Q |
|
|
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Fair Value of Other Financial Assets and Financial Liabilities by Level
The table below presents, by level within the fair value hierarchy, other financial assets and financial liabilities accounted for at fair
value primarily under the fair value option.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ in millions |
|
|
Level 1 |
|
|
|
Level 2 |
|
|
|
Level 3 |
|
|
|
Total |
|
As of March 2016 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Securities segregated for regulatory and other purposes |
|
|
$17,681 |
|
|
|
$ 21,824 |
|
|
|
$ |
|
|
|
$ 39,505 |
|
|
|
Securities purchased under agreements to resell |
|
|
|
|
|
|
127,189 |
|
|
|
|
|
|
|
127,189 |
|
|
|
Securities borrowed |
|
|
|
|
|
|
66,212 |
|
|
|
|
|
|
|
66,212 |
|
|
|
Receivables from customers and counterparties |
|
|
|
|
|
|
3,850 |
|
|
|
43 |
|
|
|
3,893 |
|
Total |
|
|
$17,681 |
|
|
|
$ 219,075 |
|
|
|
$ 43 |
|
|
|
$ 236,799 |
|
Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deposits |
|
|
$ |
|
|
|
$ (12,449 |
) |
|
|
$ (2,585 |
) |
|
|
$ (15,034 |
) |
|
|
Securities sold under agreements to repurchase |
|
|
|
|
|
|
(77,544 |
) |
|
|
(73 |
) |
|
|
(77,617 |
) |
|
|
Securities loaned |
|
|
|
|
|
|
(972 |
) |
|
|
|
|
|
|
(972 |
) |
|
|
Other secured financings |
|
|
|
|
|
|
(23,565 |
) |
|
|
(829 |
) |
|
|
(24,394 |
) |
|
|
Unsecured short-term borrowings |
|
|
|
|
|
|
(15,079 |
) |
|
|
(4,167 |
) |
|
|
(19,246 |
) |
|
|
Unsecured long-term borrowings |
|
|
|
|
|
|
(19,748 |
) |
|
|
(5,923 |
) |
|
|
(25,671 |
) |
|
|
Other liabilities and accrued expenses |
|
|
|
|
|
|
(503 |
) |
|
|
(73 |
) |
|
|
(576 |
) |
Total |
|
|
$ |
|
|
|
$(149,860 |
) |
|
|
$(13,650 |
) |
|
|
$(163,510 |
) |
As of December 2015 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Securities segregated for regulatory and other purposes |
|
|
$19,562 |
|
|
|
$ 18,942 |
|
|
|
$ |
|
|
|
$ 38,504 |
|
|
|
Securities purchased under agreements to resell |
|
|
|
|
|
|
119,450 |
|
|
|
|
|
|
|
119,450 |
|
|
|
Securities borrowed |
|
|
|
|
|
|
69,801 |
|
|
|
|
|
|
|
69,801 |
|
|
|
Receivables from customers and counterparties |
|
|
|
|
|
|
4,947 |
|
|
|
45 |
|
|
|
4,992 |
|
Total |
|
|
$19,562 |
|
|
|
$ 213,140 |
|
|
|
$ 45 |
|
|
|
$ 232,747 |
|
Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deposits |
|
|
$ |
|
|
|
$ (12,465 |
) |
|
|
$ (2,215 |
) |
|
|
$ (14,680 |
) |
|
|
Securities sold under agreements to repurchase |
|
|
|
|
|
|
(85,998 |
) |
|
|
(71 |
) |
|
|
(86,069 |
) |
|
|
Securities loaned |
|
|
|
|
|
|
(466 |
) |
|
|
|
|
|
|
(466 |
) |
|
|
Other secured financings |
|
|
|
|
|
|
(22,658 |
) |
|
|
(549 |
) |
|
|
(23,207 |
) |
|
|
Unsecured short-term borrowings |
|
|
|
|
|
|
(13,610 |
) |
|
|
(4,133 |
) |
|
|
(17,743 |
) |
|
|
Unsecured long-term borrowings |
|
|
|
|
|
|
(18,049 |
) |
|
|
(4,224 |
) |
|
|
(22,273 |
) |
|
|
Other liabilities and accrued expenses |
|
|
|
|
|
|
(1,201 |
) |
|
|
(52 |
) |
|
|
(1,253 |
) |
Total |
|
|
$ |
|
|
|
$(154,447 |
) |
|
|
$(11,244 |
) |
|
|
$(165,691 |
) |
In the table above:
|
|
Securities segregated for regulatory and other purposes include segregated securities accounted for at fair
value under the fair value option and consists of securities borrowed and resale agreements. |
|
|
Level 1 other financial assets at fair value include U.S. Treasury securities segregated for regulatory
and other purposes accounted for at fair value under other U.S. GAAP. |
|
|
Other financial assets are shown as positive amounts and other financial liabilities are shown as negative
amounts. |
Valuation Techniques and Significant Inputs
Other financial assets and financial liabilities at fair value are generally valued based on discounted cash flow techniques, which incorporate
inputs with reasonable levels of price transparency, and are generally classified as level 2 because the inputs are observable. Valuation adjustments may be made for liquidity and for counterparty and the firms credit quality.
See below for information about the significant inputs used to value other financial assets and financial liabilities at fair value, including
the ranges of significant unobservable inputs used to value the level 3 instruments within these categories. These ranges represent the significant unobservable inputs that were used in the valuation of each type of other financial assets and
financial liabilities at fair value. The ranges and weighted averages of these inputs are not representative of the appropriate inputs to use when calculating the fair value of any one instrument. For example, the highest yield presented below for
other secured financings is appropriate for valuing a specific agreement in that category but may not be appropriate for valuing any other agreements in that category. Accordingly, the ranges of inputs presented below do not represent uncertainty
in, or possible ranges of, fair value measurements of the firms level 3 other financial assets and financial liabilities.
Resale and Repurchase Agreements and Securities Borrowed and Loaned. The significant inputs to the valuation of resale and repurchase agreements and securities
borrowed and loaned are funding spreads, the amount and timing of expected future cash flows and interest rates. As of both March 2016 and December 2015, the firm had no level 3 resale agreements, securities borrowed or securities
loaned. As of both March 2016 and December 2015, the firms level 3 repurchase agreements were not material. See Note 10 for further information about collateralized agreements and financings.
|
|
|
|
|
|
|
Goldman Sachs March 2016 Form 10-Q |
|
35 |
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Other Secured Financings. The significant inputs to the valuation of other secured financings at fair value are the amount and timing of expected future cash flows, interest rates, funding spreads, the fair value of the collateral
delivered by the firm (which is determined using the amount and timing of expected future cash flows, market prices, market yields and recovery assumptions) and the frequency of additional collateral calls. The ranges of significant unobservable
inputs used to value level 3 other secured financings are as follows:
As of March 2016:
|
|
Yield: 0.5% to 10.0% (weighted average: 3.1%) |
|
|
Duration: 1.3 to 8.6 years (weighted average: 2.5 years) |
As of December 2015:
|
|
Yield: 0.6% to 10.0% (weighted average: 2.7%) |
|
|
Duration: 1.6 to 8.8 years (weighted average: 2.8 years) |
Generally, increases in funding spreads, yield or duration, in isolation, would result in a lower fair value measurement. Due to the
distinctive nature of each of the firms level 3 other secured financings, the interrelationship of inputs is not necessarily uniform across such financings. See Note 10 for further information about collateralized agreements and
financings.
Unsecured Short-term and Long-term Borrowings. The significant inputs to the valuation of unsecured short-term and long-term borrowings at fair value are the amount and timing of expected future cash flows, interest rates, the credit spreads of the firm, as
well as commodity prices in the case of prepaid commodity transactions. The inputs used to value the embedded derivative component of hybrid financial instruments are consistent with the inputs used to value the firms other derivative
instruments. See Note 7 for further information about derivatives. See Notes 15 and 16 for further information about unsecured short-term and long-term borrowings, respectively.
Certain of the firms unsecured short-term and long-term borrowings are included in level 3, substantially all of which are hybrid
financial instruments. As the significant unobservable inputs used to value hybrid financial instruments primarily relate to the embedded derivative component of these borrowings, these inputs are incorporated in the firms derivative
disclosures related to unobservable inputs in Note 7.
Receivables from Customers and Counterparties. Receivables from customers and counterparties at fair value are primarily comprised of transfers of assets accounted for as secured loans rather than purchases. The significant inputs to the valuation of such
receivables are commodity prices, interest rates, the amount and timing of expected future cash flows and funding spreads. As of both March 2016 and December 2015, the firms level 3 receivables from customers and counterparties
were not material.
Deposits. The
significant inputs to the valuation of time deposits are interest rates and the amount and timing of future cash flows. The inputs used to value the embedded derivative component of hybrid financial instruments are consistent with the inputs used to
value the firms other derivative instruments. See Note 7 for further information about derivatives. See Note 14 for further information about deposits.
The firms deposits that are included in level 3 are hybrid financial instruments. As the significant unobservable inputs used to
value hybrid financial instruments primarily relate to the embedded derivative component of these deposits, these inputs are incorporated in the firms derivative disclosures related to unobservable inputs in Note 7.
Transfers Between Levels of the Fair Value Hierarchy
Transfers between levels of the fair value hierarchy are reported at the beginning of the reporting period in which they occur. There were no
transfers of other financial assets and financial liabilities between level 1 and level 2 during the three months ended March 2016 and March 2015. The table below presents information about transfers between level 2 and
level 3.
|
|
|
|
|
36 |
|
Goldman Sachs March 2016 Form 10-Q |
|
|
THE GOLDMAN SACHS GROUP, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Level 3 Rollforward
The table below presents changes in fair value for other financial assets and financial
liabilities accounted for at fair value categorized as level 3 as of the end of the period. In the table below:
|
|
If a financial asset or financial liability was transferred to level 3 during a reporting period, its
entire gain or loss for the period is included in level 3. For level 3 other financial assets, increases are shown as positive amounts, while decreases are shown as negative amounts. For level 3 other financial liabilities, increases
are shown as negative amounts, while decreases are shown as positive amounts. |
|
|
Level 3 other financial assets and liabilities are frequently economically hedged with cash instruments
and derivatives. Accordingly, gains or losses that are reported in level 3 can be partially offset by gains or losses attributable to level 1, 2 or 3 cash instruments or derivatives. As a result, gains or losses included in the
level 3 rollforward below do not necessarily represent the overall impact on the firms results of operations, liquidity or capital resources. |
|
|
Net unrealized gains/(losses) relate to instruments that were still held at period-end.
|
|
|
For the three months ended March 2016, the net realized and unrealized losses on level 3 other
financial liabilities of $102 million (reflecting $16 million of realized losses and $86 million of unrealized losses) include losses of approximately $150 million, $3 million and $2 million reported in Market
making, Other principal transactions and Interest expense, respectively, in the condensed consolidated statements of earnings and gains of $53 million reported in Debt valuation adjustment in the
condensed consolidated statements of comprehensive income. |
|
|
For the three months ended March 2015, the net realized and unrealized losses on level 3 other
financial liabilities of $247 million (reflecting $20 million of realized losses and $227 million of unrealized losses) include losses of approximately $9 million, $231 million and $7 million reported in Market
making, Other principal transactions and Interest expense, respectively. |
|
|
See Level 3 Rollforward Commentary below for an explanation of the net unrealized
gains/(losses) on level 3 other financial assets and liabilities and the activity related to transfers into and out of level 3.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Level 3 Other Financial Assets and Liabilities at Fair Value |
|
$ in millions |
|
|
Balance, beginning of period |
|
|
|
Net realized gains/ (losses) |
|
|
|
Net unrealized gains/ (losses) |
|
|
|
Purchases |
|
|
|
Sales |
|
|
|
Issuances |
|
|
|
Settlements |
|
|
|
Transfers into
level 3 |
|
|
|
Transfers out of
level 3 |
|
|
|
Balance, end of
period |
|
Three Months Ended March 2016 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Receivables from customers and counterparties |
|
|
$ 45 |
|
|
|
$ |
|
|
|
$ (1 |
) |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ (1 |
) |
|
|
$ |
|
|
|
$ |
|
|
|
$ 43 |
|
Total other financial assets |
|
|
$ 45 |
|
|
|
$ |
|
|
|
$ (1 |
) |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ (1 |
) |
|
|
$ |
|
|
|
$ |
|
|
|
$ 43 |
|
Deposits |
|
|
$ (2,215 |
) |
|
|
$ (2 |
) |
|
|
$(103 |
) |
|
|
$ |
|
|
|
$ |
|
|
|
$ (273 |
) |
|
|
$ 8 |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ (2,585 |
) |
|
|
Securities sold under agreements to repurchase |
|
|
(71 |
) |
|
|
|
|
|
|
(2 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(73 |
) |
|
|
Other secured financings |
|
|
(549 |
) |
|
|
6 |
|
|
|
(34 |
) |
|
|
|
|
|
|
|
|
|
|
(225 |
) |
|
|
7 |
|
|
|
(45 |
) |
|
|
11 |
|
|
|
(829 |
) |
|
|
Unsecured short-term borrowings |
|
|
(4,133 |
) |
|
|
(16 |
) |
|
|
17 |
|
|
|
|
|
|
|
|
|
|
|
(1,159 |
) |
|
|
1,450 |
|
|
|
(492 |
) |
|
|
166 |
|
|
|
(4,167 |
) |
|
|
Unsecured long-term borrowings |
|
|
(4,224 |
) |
|
|
(6 |
) |
|
|
36 |
|
|
|
(2 |
) |
|
|
|
|
|
|
(1,893 |
) |
|
|
39 |
|
|
|
(136 |
) |
|
|
263 |
|
|
|
(5,923 |
) |
|
|
Other liabilities and accrued expenses |
|
|
(52 |
) |
|
|
2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(23 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(73 |
) |
Total other financial liabilities |
|
|
$(11,244 |
) |
|
|
$(16 |
) |
|
|
$ (86 |